##ANALYSISTYPE=CLINCNV_GERMLINE_SINGLE
##gender of sample: M
##number of iterations: 1 , quality used at final iteration: 20
##was it outlier after clustering? FALSE
##fraction of outliers: 0.03
#chr	start	end	CN_change	loglikelihood	no_of_regions	length_KB	potential_AF	genes	qvalue	cn_polymorphisms_zarrei	cn_polymorphisms_demidov	dosage_sensitive_disease_genes	omim
chr1	979479	979829	3	3	2	    0.350	0.146	AGRN	0.01028	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	982190	982347	3	3	1	    0.157	0.089	AGRN	0.00875	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	984237	984841	1	4	2	    0.604	0.140	AGRN	0.02007	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	1960540	1961211	3	5	2	    0.671	0.115	GABRD	0.00838			GABRD	137163_[GABRD_Epilepsy,generalized,with_febrile_seizures_plus,type_5,susceptibility_to,613060/Epilepsy,idiopathic_generalized,10,613060/Epilepsy,juvenile_myoclonic,susceptibility_to,613060]
chr1	5940164	5947536	3	3	2	    7.372	0.064	NPHP4	0.02784				607215_[NPHP4_Nephronophthisis_4,606966/Senior-Loken_syndrome_4,606996]
chr1	6534501	6535208	4	4	2	    0.707	0.248	PLEKHG5	0.01219				611101_[PLEKHG5_Spinal_muscular_atrophy,distal,autosomal_recessive,4,611067/Charcot-Marie-Tooth_disease,recessive_intermediate_C,615376]
chr1	10355134	10355233	3	4	1	    0.099	0.108	KIF1B	0.00437				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10386159	10386427	3	4	1	    0.268	0.025	KIF1B	0.00144				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10420977	10421111	3	6	1	    0.134	0.102	KIF1B	0.00092				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10434902	10435114	3	3	1	    0.212	0.006	KIF1B	0.00708				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10435303	10435441	1	5	1	    0.138	0.083	KIF1B	0.00059				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	11853954	11854156	3	3	1	    0.202	0.089	MTHFR	0.00473				607093_[MTHFR_Homocystinuria_due_to_MTHFR_deficiency,236250/Schizophrenia,susceptibility_to,181500/Vascular_disease,susceptibility_to/Neural_tube_defects,susceptibility_to,601634/Thromboembolism,susceptibility_to,188050]
chr1	12014877	12017081	3	4	2	    2.204	0.013	PLOD1	0.01585				153454_[PLOD1_Ehlers-Danlos_syndrome,kyphoscoliotic_type,1,225400]
chr1	12027034	12033064	3	4	3	    6.030	0.089	PLOD1	0.01950				153454_[PLOD1_Ehlers-Danlos_syndrome,kyphoscoliotic_type,1,225400]
chr1	19202799	19204116	1	4	2	    1.317	0.038	ALDH4A1	0.00776				606811_[ALDH4A1_Hyperprolinemia,type_II,239510]
chr1	19217178	19217395	3	4	1	    0.217	0.127	ALDH4A1	0.00540				606811_[ALDH4A1_Hyperprolinemia,type_II,239510]
chr1	22169253	22179335	3	14	16	   10.082	0.108	HSPG2	0.01793			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22202112	22202250	3	4	1	    0.138	0.115	HSPG2	0.00411			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22204669	22204756	4	10	1	    0.087	0.197	HSPG2	0.00004			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22206846	22207338	1	6	2	    0.492	0.057	HSPG2	0.00098			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22213698	22214177	3	6	2	    0.479	0.223	HSPG2	0.00204			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	26136164	26138380	3	12	3	    2.216	0.108	SELENON	0.01366				606210_[SELENON_Muscular_dystrophy,rigid_spine,1,602771/Myopathy,congenital,with_fiber-type_disproportion,255310]
chr1	26503971	26504100	3	6	1	    0.129	0.102	CNKSR1	0.00056				
chr1	26506934	26507397	1	5	2	    0.463	0.115	CNKSR1	0.00248				
chr1	27057633	27058105	3	7	1	    0.472	0.102	ARID1A	0.00029			ARID1A	603024_[ARID1A_Coffin-Siris_syndrome_2,614607]
chr1	27059157	27059293	1	3	1	    0.136	0.051	ARID1A	0.00904			ARID1A	603024_[ARID1A_Coffin-Siris_syndrome_2,614607]
chr1	27699617	27700952	1	4	2	    1.335	0.121	FCN3	0.01856				604973_[FCN3_Immunodeficiency_due_to_ficolin_3_deficiency,613860]
chr1	33251953	33252686	3	3	2	    0.733	0.070	YARS	0.00892				603623_[YARS_Charcot-Marie-Tooth_disease,dominant_intermediate_C,608323]
chr1	44201894	44202106	3	4	1	    0.212	0.032	ST3GAL3	0.00144				606494_[ST3GAL3_Mental_retardation,autosomal_recessive_12,611090/Epileptic_encephalopathy,early_infantile,15,615006]
chr1	45287928	45289067	3	5	3	    1.139	0.153	PTCH2	0.01893				603673_[PTCH2_Medulloblastoma,somatic,155255/Basal_cell_carcinoma,somatic,605462/Basal_cell_nevus_syndrome,109400]
chr1	45292564	45293396	1	1	3	    0.832	0.096	PTCH2	0.00367				603673_[PTCH2_Medulloblastoma,somatic,155255/Basal_cell_carcinoma,somatic,605462/Basal_cell_nevus_syndrome,109400]
chr1	45295571	45296725	1	7	2	    1.154	0.134	PTCH2	0.00997				603673_[PTCH2_Medulloblastoma,somatic,155255/Basal_cell_carcinoma,somatic,605462/Basal_cell_nevus_syndrome,109400]
chr1	45363017	45363126	1	5	1	    0.109	0.064	EIF2B3	0.00154				606273_[EIF2B3_Leukoencephalopathy_with_vanishing_white_matter,603896]
chr1	46660506	46661606	1	3	2	    1.100	0.108	POMGNT1	0.00902			POMGNT1	606822_[POMGNT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,3,253280/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,3,613151/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,3,613157/Retinitis_pigmentosa_76,617123]
chr1	53458920	53459914	3	4	1	    0.994	0.076	SCP2	0.00480				184755_[SCP2_Leukoencephalopathy_with_dystonia_and_motor_neuropathy,613724]
chr1	55337013	55337296	3	3	1	    0.283	0.076	DHCR24	0.00234				606418_[DHCR24_Desmosterolosis,602398]
chr1	55352552	55465046	3	4	2	  112.494	0.121	DHCR24,BSND	0.02345			BSND	606418_[DHCR24_Desmosterolosis,602398],606412_[BSND_Bartter_syndrome,type_4a,602522/Sensorineural_deafness_with_mild_renal_dysfunction,602522]
chr1	92948920	92949153	4	4	1	    0.233	0.159	GFI1	0.00151				600871_[GFI1_Neutropenia,severe_congenital_2,autosomal_dominant,613107/Neutropenia,nonimmune_chronic_idiopathic,of_adults,607847]
chr1	110737191	110737403	1	3	1	    0.212	0.076	SLC6A17	0.00508				610299_[SLC6A17_Mental_retardation,autosomal_recessive_48,616269]
chr1	151316147	151316368	1	4	1	    0.221	0.134	RFX5	0.00252				601863_[RFX5_Bare_lymphocyte_syndrome,type_II,complementation_group_C,209920/Bare_lymphocyte_syndrome,type_II,complementation_group_E,209920]
chr1	151317194	151317333	1	3	1	    0.139	0.134	RFX5	0.00405				601863_[RFX5_Bare_lymphocyte_syndrome,type_II,complementation_group_C,209920/Bare_lymphocyte_syndrome,type_II,complementation_group_E,209920]
chr1	154145374	154145464	3	3	1	    0.090	0.064	TPM3	0.00526				191030_[TPM3_Nemaline_myopathy_1,autosomal_dominant_or_recessive,609284/CAP_myopathy_1,609284/Myopathy,congenital,with_fiber-type_disproportion,255310]
chr1	154543655	154544647	5	5	1	    0.992	0.331	CHRNB2	0.00222			CHRNB2	118507_[CHRNB2_Epilepsy,nocturnal_frontal_lobe,3,605375]
chr1	155262958	155263391	1	4	2	    0.433	0.089	PKLR	0.00373				609712_[PKLR_Pyruvate_kinase_deficiency,266200/Adenosine_triphosphate,elevated,of_erythrocytes,102900]
chr1	155264016	155264553	3	3	2	    0.537	0.070	PKLR	0.00999				609712_[PKLR_Pyruvate_kinase_deficiency,266200/Adenosine_triphosphate,elevated,of_erythrocytes,102900]
chr1	155740848	155741018	3	4	1	    0.170	0.140	GON4L	0.00712				
chr1	155784111	155792277	3	9	4	    8.166	0.051	GON4L	0.00053				
chr1	156100398	156100574	1	4	1	    0.176	0.121	LMNA	0.00552			LMNA	150330_[LMNA_Emery-Dreifuss_muscular_dystrophy_2,autosomal_dominant,181350/Cardiomyopathy,dilated,1A,115200/Lipodystrophy,familial_partial,type_2,151660/Emery-Dreifuss_muscular_dystrophy_3,autosomal_recessive,616516/Charcot-Marie-Tooth_disease,type_2B1,605588/Muscular_dystrophy,congenital,613205/Mandibuloacral_dysplasia,248370/Hutchinson-Gilford_progeria,176670/Restrictive_dermopathy,lethal,275210/Heart-hand_syndrome,Slovenian_type,610140/Malouf_syndrome,212112]
chr1	156104968	156105113	1	5	1	    0.145	0.102	LMNA	0.00241			LMNA	150330_[LMNA_Emery-Dreifuss_muscular_dystrophy_2,autosomal_dominant,181350/Cardiomyopathy,dilated,1A,115200/Lipodystrophy,familial_partial,type_2,151660/Emery-Dreifuss_muscular_dystrophy_3,autosomal_recessive,616516/Charcot-Marie-Tooth_disease,type_2B1,605588/Muscular_dystrophy,congenital,613205/Mandibuloacral_dysplasia,248370/Hutchinson-Gilford_progeria,176670/Restrictive_dermopathy,lethal,275210/Heart-hand_syndrome,Slovenian_type,610140/Malouf_syndrome,212112]
chr1	156105682	156105922	3	5	1	    0.240	0.096	LMNA	0.00122			LMNA	150330_[LMNA_Emery-Dreifuss_muscular_dystrophy_2,autosomal_dominant,181350/Cardiomyopathy,dilated,1A,115200/Lipodystrophy,familial_partial,type_2,151660/Emery-Dreifuss_muscular_dystrophy_3,autosomal_recessive,616516/Charcot-Marie-Tooth_disease,type_2B1,605588/Muscular_dystrophy,congenital,613205/Mandibuloacral_dysplasia,248370/Hutchinson-Gilford_progeria,176670/Restrictive_dermopathy,lethal,275210/Heart-hand_syndrome,Slovenian_type,610140/Malouf_syndrome,212112]
chr1	156834510	156834601	1	6	1	    0.091	0.102	NTRK1	0.00049				191315_[NTRK1_Insensitivity_to_pain,congenital,with_anhidrosis,256800/Medullary_thyroid_carcinoma,familial,155240]
chr1	173793787	173795934	1	3	2	    2.147	0.019	DARS2	0.00504				610956_[DARS2_Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement_and_lactate_elevation,611105]
chr1	173800663	173806194	1	9	3	    5.531	0.096	DARS2	0.01358		yes		610956_[DARS2_Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement_and_lactate_elevation,611105]
chr1	196712572	196716644	3	6	3	    4.072	0.038	CFH	0.00886	yes			134370_[CFH_Hemolytic_uremic_syndrome,atypical,susceptibility_to,1,235400/Complement_factor_H_deficiency,609814/Macular_degeneration,age-related,4,610698/Basal_laminar_drusen,126700]
chr1	197113077	197115834	1	4	2	    2.757	0.299	ASPM	0.10186				605481_[ASPM_Microcephaly_5,primary,autosomal_recessive,608716]
chr1	198691535	198691615	1	3	1	    0.080	0.580	PTPRC	0.20443				151460_[PTPRC_Hepatitis_C_virus,susceptibility_to,609532/Severe_combined_immunodeficiency,T_cell-negative,B-cell/natural_killer-cell_positive,608971]
chr1	198703447	198711165	1	3	3	    7.718	0.242	PTPRC	0.11269				151460_[PTPRC_Hepatitis_C_virus,susceptibility_to,609532/Severe_combined_immunodeficiency,T_cell-negative,B-cell/natural_killer-cell_positive,608971]
chr1	201009349	201009851	1	7	2	    0.502	0.127	CACNA1S	0.00930				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201030385	201030606	3	4	1	    0.221	0.127	CACNA1S	0.00715				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201046038	201052460	3	8	3	    6.422	0.102	CACNA1S	0.00144				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201056944	201058601	3	6	2	    1.657	0.115	CACNA1S	0.00215				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	209790745	209790941	1	5	1	    0.196	0.115	LAMB3	0.00323				150310_[LAMB3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Amelogenesis_imperfecta,type_IA,104530]
chr1	209969683	209974771	1	3	2	    5.088	0.127	IRF6	0.08245			IRF6	607199_[IRF6_van_der_Woude_syndrome,119300/Popliteal_pterygium_syndrome_1,119500/Orofacial_cleft_6,608864]
chr1	215853481	215853728	1	6	1	    0.247	0.045	USH2A	0.00023				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	215931927	215932104	3	7	1	    0.177	0.038	USH2A	0.00066				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	216172219	216172410	3	3	1	    0.191	0.070	USH2A	0.00989				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	216465507	216465722	3	3	1	    0.215	0.083	USH2A	0.00215				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	225606955	225609989	1	5	3	    3.034	0.089	LBR	0.04457				600024_[LBR_Pelger-Huet_anomaly,169400/Greenberg_skeletal_dysplasia,215140/Reynolds_syndrome,613471/Pelger-Huet_anomaly_with_mild_skeletal_anomalies,618019]
chr1	227153362	227165234	1	3	2	   11.872	0.121	COQ8A	0.01929				606980_[COQ8A_Coenzyme_Q10_deficiency,primary,4,612016]
chr1	229566983	229568884	3	5	6	    1.901	0.255	ACTA1	0.05321				102610_[ACTA1_Nemaline_myopathy_3,autosomal_dominant_or_recessive,161800/Myopathy,actin,congenital,with_excess_of_thin_myofilaments,161800/Myopathy,actin,congenital,with_cores,161800/Myopathy,congenital,with_fiber-type_disproportion_1,255310/Myopathy,scapulohumeroperoneal,616852]
chr1	235599691	235599933	3	2	2	    0.242	0.102	TBCE	0.06226			TBCE	604934_[TBCE_Kenny-Caffey_syndrome,type_1,244460/Hypoparathyroidism-retardation-dysmorphism_syndrome,241410/Encephalopathy,progressive,with_amyotrophy_and_optic_atrophy,617207]
chr1	235860373	235866287	1	4	2	    5.914	0.159	LYST	0.05143				606897_[LYST_Chediak-Higashi_syndrome,214500]
chr1	235914500	235914672	3	6	1	    0.172	0.070	LYST	0.00048				606897_[LYST_Chediak-Higashi_syndrome,214500]
chr1	236979739	236979853	1	4	1	    0.114	0.127	MTR	0.00468				156570_[MTR_Homocystinuria-megaloblastic_anemia,cblG_complementation_type,250940/Neural_tube_defects,folate-sensitive,susceptibility_to,601634]
chr2	11935524	11935623	1	4	1	    0.099	0.127	LPIN1	0.00576				605518_[LPIN1_Myoglobinuria,acute_recurrent,autosomal_recessive,268200]
chr2	26459713	26459866	3	3	1	    0.153	0.064	HADHA	0.00760				600890_[HADHA_LCHAD_deficiency,609016/Trifunctional_protein_deficiency,609015/HELLP_syndrome,maternal,of_pregnancy,609016/Fatty_liver,acute,of_pregnancy,609016]
chr2	26505703	26507082	1	9	2	    1.379	0.019	HADHB	0.00005				143450_[HADHB_Trifunctional_protein_deficiency,609015]
chr2	39237715	39237854	3	3	1	    0.139	0.127	SOS1	0.01042			SOS1	182530_[SOS1_Fibromatosis,gingival,1,135300/Noonan_syndrome_4,610733]
chr2	44145385	44145547	1	3	1	    0.162	0.070	LRPPRC	0.00480				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	44187670	44187783	3	4	1	    0.113	0.134	LRPPRC	0.00577				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	44206955	44209583	1	6	2	    2.628	0.083	LRPPRC	0.00713				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	46524531	46583957	3	6	4	   59.426	0.096	EPAS1	0.03556				603349_[EPAS1_Erythrocytosis,familial,4,611783]
chr2	48958356	48958447	1	7	1	    0.091	0.102	LHCGR,STON1-GTF2A1L	0.00114				152790_[LHCGR_Precocious_puberty,male,176410/Leydig_cell_hypoplasia_with_pseudohermaphroditism,238320/Leydig_cell_hypoplasia_with_hypergonadotropic_hypogonadism,238320/Luteinizing_hormone_resistance,female,238320/Leydig_cell_adenoma,somatic,with_precocious_puberty,176410]
chr2	69569274	69569391	1	3	1	    0.117	0.134	GFPT1	0.02821				138292_[GFPT1_Myasthenia,congenital,12,with_tubular_aggregates,610542]
chr2	69575293	69575476	3	3	1	    0.183	0.051	GFPT1	0.00217				138292_[GFPT1_Myasthenia,congenital,12,with_tubular_aggregates,610542]
chr2	71708999	71709110	1	3	1	    0.111	0.070	DYSF	0.00576				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71783085	71783211	1	3	1	    0.126	0.127	DYSF	0.00929				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71801318	71816826	3	3	2	   15.508	0.045	DYSF	0.02281				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71839761	71840550	1	7	2	    0.789	0.076	DYSF	0.00122				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71909650	71909817	3	6	1	    0.167	0.089	DYSF	0.00145				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	73653571	73653691	3	5	1	    0.120	0.096	ALMS1	0.00187				606844_[ALMS1_Alstrom_syndrome,203800]
chr2	74590111	74592794	1	11	4	    2.683	0.102	DCTN1	0.00185				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	74594469	74594557	1	4	1	    0.088	0.172	DCTN1	0.00335				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	74595088	74595268	1	5	1	    0.180	0.019	DCTN1	0.00123				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	74605117	74605382	1	5	1	    0.265	0.121	DCTN1	0.00237				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	86459738	86459935	3	6	1	    0.197	0.166	REEP1	0.00042				609139_[REEP1_Spastic_paraplegia_31,autosomal_dominant,610250/Neuronopathy,distal_hereditary_motor,type_VB,614751]
chr2	98341545	98351929	3	5	5	   10.384	0.076	ZAP70	0.05242				176947_[ZAP70_Autoimmune_disease,multisystem,infantile-onset,2,617006/Immunodeficiency_48,269840]
chr2	99160330	99162546	3	3	2	    2.216	0.076	INPP4A	0.08685				
chr2	99181093	99182239	1	3	2	    1.146	0.096	INPP4A	0.01220				
chr2	106468194	106468363	3	6	1	    0.169	0.121	NCK2	0.00049			NCK2	
chr2	109370271	109370437	3	4	1	    0.166	0.127	RANBP2	0.00481				601181_[RANBP2_Encephalopathy,acute,infection-induced,3,susceptibility_to,608033]
chr2	110886753	110886846	1	3	1	    0.093	0.140	NPHP1	0.00940			NPHP1	607100_[NPHP1_Nephronophthisis_1,juvenile,256100/Senior-Loken_syndrome-1,266900/Joubert_syndrome_4,609583]
chr2	110927373	110927585	3	4	1	    0.212	0.127	NPHP1	0.00246			NPHP1	607100_[NPHP1_Nephronophthisis_1,juvenile,256100/Senior-Loken_syndrome-1,266900/Joubert_syndrome_4,609583]
chr2	113819691	113819838	1	3	1	    0.147	0.127	IL36RN	0.00508				605507_[IL36RN_Psoriasis_14,pustular,614204]
chr2	113994168	113994308	3	4	1	    0.140	0.115	PAX8,PAX8-AS1	0.00480			PAX8	167415_[PAX8_Hypothyroidism,congenital,due_to_thyroid_dysgenesis_or_hypoplasia,218700]
chr2	121740282	121740466	1	4	1	    0.184	0.096	GLI2	0.00636			GLI2	165230_[GLI2_Holoprosencephaly_9,610829/Culler-Jones_syndrome,615849]
chr2	121743844	121744200	3	5	1	    0.356	0.083	GLI2	0.00125			GLI2	165230_[GLI2_Holoprosencephaly_9,610829/Culler-Jones_syndrome,615849]
chr2	127808720	127809948	1	8	2	    1.228	0.064	BIN1	0.00336				601248_[BIN1_Centronuclear_myopathy_2,255200]
chr2	127815039	127821604	3	8	5	    6.565	0.089	BIN1	0.01806				601248_[BIN1_Centronuclear_myopathy_2,255200]
chr2	152348891	152349018	1	3	1	    0.127	0.102	NEB	0.00335				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152442909	152448662	3	6	5	    5.753	0.159	NEB	0.00328				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152459091	152465200	3	3	6	    6.109	0.178	NEB	0.03539		yes		161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152470780	152471111	3	4	1	    0.331	0.172	NEB	0.00544				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152482038	152490489	3	10	7	    8.451	0.096	NEB	0.00303				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152496859	152497190	3	5	1	    0.331	0.115	NEB	0.00073				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152500322	152500653	3	4	1	    0.331	0.108	NEB	0.00380				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152512657	152512988	3	3	1	    0.331	0.096	NEB	0.03190				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152521005	152521132	1	3	1	    0.127	0.102	NEB	0.00603				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152536422	152537352	3	7	2	    0.930	0.096	NEB	0.00041				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152590216	152590319	1	6	1	    0.103	0.064	NEB	0.00085				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	169853135	169853242	3	3	1	    0.107	0.197	ABCB11	0.00805				603201_[ABCB11_Cholestasis,progressive_familial_intrahepatic_2,601847/Cholestasis,benign_recurrent_intrahepatic,2,605479]
chr2	170059256	170059479	1	4	1	    0.223	0.051	LRP2	0.00387			LRP2	600073_[LRP2_Donnai-Barrow_syndrome,222448]
chr2	170127404	170127627	3	4	1	    0.223	0.146	LRP2	0.00499			LRP2	600073_[LRP2_Donnai-Barrow_syndrome,222448]
chr2	173339647	173339860	3	4	1	    0.213	0.146	ITGA6	0.00290				147556_[ITGA6_Epidermolysis_bullosa,junctional,with_pyloric_stenosis,226730]
chr2	178310264	178310364	1	7	1	    0.100	0.064	AGPS	0.00052				603051_[AGPS_Rhizomelic_chondrodysplasia_punctata,type_3,600121]
chr2	179463223	179463391	1	3	1	    0.168	0.108	TTN,TTN-AS1	0.00985				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179482042	179482249	1	4	1	    0.207	0.204	TTN,TTN-AS1	0.00326				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179499083	179499586	1	5	2	    0.503	0.076	TTN,TTN-AS1	0.01527				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179549623	179550067	1	3	2	    0.444	0.121	TTN,TTN-AS1	0.09359				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179597157	179598254	1	5	3	    1.097	0.070	TTN,TTN-AS1	0.00222				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179600228	179600811	1	4	1	    0.583	0.045	TTN,TTN-AS1	0.00235				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179641866	179642712	1	2	3	    0.846	0.070	TTN	0.02803				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179644717	179644942	1	3	1	    0.225	0.083	TTN	0.01055				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179669269	179672160	1	5	2	    2.891	0.140	TTN	0.02113				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	198363389	198363584	1	3	1	    0.195	0.121	HSPD1	0.01582				118190_[HSPD1_Spastic_paraplegia_13,autosomal_dominant,605280/Leukodystrophy,hypomyelinating,4,612233]
chr2	202572582	202574771	1	3	2	    2.189	0.083	ALS2	0.04209				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	202587756	202587853	1	4	1	    0.097	0.121	ALS2	0.00587				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	202608971	202609162	3	3	1	    0.191	0.057	ALS2	0.00215				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	202631942	202632116	3	3	1	    0.174	0.064	ALS2	0.00214				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	207652651	207655420	1	6	3	    2.769	0.089	FASTKD2	0.01531				612322_[FASTKD2_Mitochondrial_complex_IV_deficiency,220110]
chr2	215802224	215807751	3	6	2	    5.527	0.083	ABCA12	0.01419				607800_[ABCA12_Ichthyosis,congenital,autosomal_recessive_4A,601277/Ichthyosis,congenital,autosomal_recessive_4B_(harlequin),242500]
chr2	215822991	215823188	3	8	1	    0.197	0.057	ABCA12	0.00010				607800_[ABCA12_Ichthyosis,congenital,autosomal_recessive_4A,601277/Ichthyosis,congenital,autosomal_recessive_4B_(harlequin),242500]
chr2	215872441	215872580	3	5	1	    0.139	0.076	ABCA12	0.00158				607800_[ABCA12_Ichthyosis,congenital,autosomal_recessive_4A,601277/Ichthyosis,congenital,autosomal_recessive_4B_(harlequin),242500]
chr2	215882722	215882866	1	6	1	    0.144	0.121	ABCA12	0.00154				607800_[ABCA12_Ichthyosis,congenital,autosomal_recessive_4A,601277/Ichthyosis,congenital,autosomal_recessive_4B_(harlequin),242500]
chr2	220025432	220025597	3	3	1	    0.165	0.159	NHEJ1	0.00491				611290_[NHEJ1_Severe_combined_immunodeficiency_with_microcephaly,growth_retardation,and_sensitivity_to_ionizing_radiation,611291]
chr2	227896854	227912275	1	7	5	   15.421	0.197	COL4A4	0.09499	yes			120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	227919300	227945275	1	9	8	   25.975	0.134	COL4A4	0.13155				120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	228157897	228167836	1	10	5	    9.939	0.121	COL4A3	0.02080			COL4A3	120070_[COL4A3_Alport_syndrome,autosomal_recessive,203780/Hematuria,benign_familial,141200/Alport_syndrome,autosomal_dominant,104200]
chr2	231086410	231086509	3	8	1	    0.099	0.083	SP110	0.00006				604457_[SP110_Hepatic_venoocclusive_disease_with_immunodeficiency,235550/Mycobacterium_tuberculosis,susceptibility_to,607948]
chr2	233394639	233396183	3	4	2	    1.544	0.108	CHRND	0.00001				100690_[CHRND_Myasthenic_syndrome,congenital,1A,slow-channel,601462/Myasthenic_syndrome,congenital,1B,fast-channel,608930/Multiple_pterygium_syndrome,lethal_type,253290],100720_[CHRND_Myasthenic_syndrome,congenital,3A,slow-channel,616321/Myasthenic_syndrome,congenital,3B,fast-channel,616322/Myasthenic_syndrome,congenital,3C,associated_with_acetylcholine_receptor_deficiency,616323/Multiple_pterygium_syndrome,lethal_type,253290]
chr2	238244768	238247770	1	3	2	    3.002	0.057	COL6A3	0.00145				120250_[COL6A3_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090/Dystonia_27,616411]
chr2	238268721	238268812	3	7	1	    0.091	0.108	COL6A3	0.00013				120250_[COL6A3_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090/Dystonia_27,616411]
chr2	240002781	240003927	1	3	2	    1.146	0.115	HDAC4	0.12801			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240005841	240005948	3	3	1	    0.107	0.070	HDAC4	0.01209			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240111519	240158370	3	5	2	   46.851	0.121	HDAC4	0.00150	yes		HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	241530222	241530438	3	4	1	    0.216	0.115	CAPN10	0.00572				605286_[CAPN10_Diabetes_mellitus,noninsulin-dependent_1,601283]
chr2	241535726	241538536	1	7	3	    2.810	0.057	CAPN10	0.00401				605286_[CAPN10_Diabetes_mellitus,noninsulin-dependent_1,601283]
chr3	3197893	3197975	1	3	1	    0.082	0.102	CRBN	0.00922				609262_[CRBN_Mental_retardation,autosomal_recessive_2,607417]
chr3	4687256	4693912	1	3	2	    6.656	0.153	ITPR1	0.03646			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	4829621	4829833	3	5	1	    0.212	0.051	ITPR1	0.00144			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	8775476	8775686	3	3	1	    0.210	0.108	CAV3	0.01471				601253_[CAV3_Rippling_muscle_disease,606072/Creatine_phosphokinase,elevated_serum,123320/Myopathy,distal,Tateyama_type,614321/Cardiomyopathy,familial_hypertrophic,192600/Long_QT_syndrome_9,611818]
chr3	10084233	10084357	3	4	1	    0.124	0.134	FANCD2	0.00268				613984_[FANCD2_Fanconi_anemia,complementation_group_D2,227646]
chr3	10101968	10102097	3	5	1	    0.129	0.083	FANCD2	0.00326				613984_[FANCD2_Fanconi_anemia,complementation_group_D2,227646]
chr3	10119755	10119891	3	5	1	    0.136	0.051	FANCD2	0.00130				613984_[FANCD2_Fanconi_anemia,complementation_group_D2,227646]
chr3	12653439	12660256	1	4	2	    6.817	0.115	RAF1	0.01323	yes		RAF1	164760_[RAF1_Noonan_syndrome_5,611553/LEOPARD_syndrome_2,611554/Cardiomyopathy,dilated,1NN,615916]
chr3	13916434	13916680	1	3	1	    0.246	0.096	WNT7A	0.00835				601570_[WNT7A_Ulna_and_fibula,absence_of,with_severe_limb_deficiency,276820/Fuhrmann_syndrome,228930]
chr3	15499683	15512133	1	4	3	   12.450	0.070	COLQ	0.05813				603033_[COLQ_Myasthenic_syndrome,congenital,5,603034]
chr3	24359839	24359995	3	4	1	    0.156	0.089	THRB	0.00159				190160_[THRB_Thyroid_hormone_resistance,188570/Thyroid_hormone_resistance,autosomal_recessive,274300/Thyroid_hormone_resistance,selective_pituitary,145650]
chr3	41277830	41278210	1	2	2	    0.380	0.045	CTNNB1	0.00964				116806_[CTNNB1_Mental_retardation,autosomal_dominant_19,615075/Colorectal_cancer,somatic,114500/Pilomatricoma,somatic,132600/Ovarian_cancer,somatic,167000/Hepatocellular_carcinoma,somatic,114550/Medulloblastoma,somatic,155255/Exudative_vitreoretinopathy_7,617572]
chr3	46919226	46919343	1	4	1	    0.117	0.153	PTH1R	0.00273				168468_[PTH1R_Metaphyseal_chondrodysplasia,Murk_Jansen_type,156400/Chondrodysplasia,Blomstrand_type,215045/Eiken_syndrome,600002/Failure_of_tooth_eruption,primary,125350]
chr3	49158537	49159035	1	1	2	    0.498	0.089	LAMB2	0.01756				150325_[LAMB2_Nephrotic_syndrome,type_5,with_or_without_ocular_abnormalities,614199/Pierson_syndrome,609049]
chr3	49166668	49166767	3	3	1	    0.099	0.083	LAMB2	0.00727				150325_[LAMB2_Nephrotic_syndrome,type_5,with_or_without_ocular_abnormalities,614199/Pierson_syndrome,609049]
chr3	49456683	49456848	3	3	1	    0.165	0.083	AMT	0.00902				238310_[AMT_Glycine_encephalopathy,605899]
chr3	52019858	52019972	3	3	1	    0.114	0.070	ABHD14A-ACY1,ACY1	0.00491				104620_[ACY1_Aminoacylase_1_deficiency,609924]
chr3	58116458	58117756	1	3	2	    1.298	0.108	FLNB	0.01655				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58140508	58141812	1	5	2	    1.304	0.076	FLNB	0.00480				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58415425	58415975	1	7	2	    0.550	0.153	PDHB	0.07003				179060_[PDHB_Pyruvate_dehydrogenase_E1-beta_deficiency,614111]
chr3	63884065	63938169	3	5	3	   54.104	0.064	ATXN7	0.00287				607640_[ATXN7_Spinocerebellar_ataxia_7,164500]
chr3	81643049	81643184	3	3	1	    0.135	0.102	GBE1	0.00350				607839_[GBE1_Glycogen_storage_disease_IV,232500/Polyglucosan_body_disease,adult_form,263570]
chr3	81695533	81695643	1	4	1	    0.110	0.127	GBE1	0.00636				607839_[GBE1_Glycogen_storage_disease_IV,232500/Polyglucosan_body_disease,adult_form,263570]
chr3	121547307	121547489	3	4	1	    0.182	0.051	IQCB1	0.00328				609237_[IQCB1_Senior-Loken_syndrome_5,609254]
chr3	128628177	128629002	3	5	2	    0.825	0.102	ACAD9,KIAA1257	0.00515				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	142185156	142185385	3	8	1	    0.229	0.083	ATR	0.00006			ATR	601215_[ATR_Seckel_syndrome_1,210600/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564]
chr3	142215193	142217626	1	4	3	    2.433	0.045	ATR	0.02386			ATR	601215_[ATR_Seckel_syndrome_1,210600/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564]
chr3	142279095	142279306	3	4	1	    0.211	0.121	ATR	0.00734			ATR	601215_[ATR_Seckel_syndrome_1,210600/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564]
chr3	158363944	158364096	3	3	1	    0.152	0.115	GFM1	0.01059				606639_[GFM1_Combined_oxidative_phosphorylation_deficiency_1,609060]
chr3	159974764	159976433	3	5	1	    1.669	0.064	IFT80	0.00008				611177_[IFT80_Short-rib_thoracic_dysplasia_2_with_or_without_polydactyly,611263]
chr3	160083821	160093678	1	5	2	    9.857	0.102	IFT80	0.01220				611177_[IFT80_Short-rib_thoracic_dysplasia_2_with_or_without_polydactyly,611263]
chr3	183854390	183855873	1	4	3	    1.483	0.076	EIF2B5	0.00401				603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr3	183862375	183862505	1	6	1	    0.130	0.089	EIF2B5	0.00023				603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr3	183961332	183961428	1	4	1	    0.096	0.083	ALG3,EIF2B5	0.00613				603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896],608750_[ALG3_Congenital_disorder_of_glycosylation,type_Id,601110]
chr3	184071028	184071593	1	4	2	    0.565	0.096	CLCN2,EIF2B5	0.01042			CLCN2	603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896],600570_[CLCN2_Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628/Epilepsy,juvenile_absence,susceptibility_to,2,607628/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628/Leukoencephalopathy_with_ataxia,615651/Hyperaldosteronism,familial,type_II,605635]
chr3	196792569	196803566	3	11	2	   10.997	0.057	DLG1	0.00046			DLG1	
chr3	196831764	196831886	1	3	1	    0.122	0.121	DLG1	0.01220			DLG1	
chr3	196846271	196857552	3	4	2	   11.281	0.032	DLG1	0.00155			DLG1	
chr3	197421236	197421466	3	10	1	    0.230	0.096	RUBCN	0.00001				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197444838	197476578	1	5	2	   31.740	0.064	RUBCN,FYTTD1	0.00508				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr4	994660	997423	3	5	5	    2.763	0.248	IDUA	0.04041				252800_[IDUA_Mucopolysaccharidosis_Ih,607014/Mucopolysaccharidosis_Is,607016/Mucopolysaccharidosis_Ih/s,607015]
chr4	998038	1801260	1	4	2	  803.222	0.140	IDUA,FGFR3	0.02723	yes	yes	SLBP,FGFR3	252800_[IDUA_Mucopolysaccharidosis_Ih,607014/Mucopolysaccharidosis_Is,607016/Mucopolysaccharidosis_Ih/s,607015],612041_[RNF212_Recombination_rate_QTL_1,612042],602618_[CTBP1_Hypotonia,ataxia,developmental_delay,and_tooth_enamel_defect_syndrome,617915],614632_[UVSSA_UV-sensitive_syndrome_3,614640],134934_[FGFR3_Achondroplasia,100800/Hypochondroplasia,146000/Thanatophoric_dysplasia,type_I,187600/Crouzon_syndrome_with_acanthosis_nigricans,612247/Muenke_syndrome,602849/Bladder_cancer,somatic,109800/Colorectal_cancer,somatic,114500/Cervical_cancer,somatic,603956/LADD_syndrome,149730/CATSHL_syndrome,610474/Nevus,epidermal,somatic,162900/Thanatophoric_dysplasia,type_II,187601/Spermatocytic_seminoma,somatic,273300/SADDAN,616482]
chr4	1806047	1806706	1	3	2	    0.659	0.032	FGFR3	0.00515			FGFR3	134934_[FGFR3_Achondroplasia,100800/Hypochondroplasia,146000/Thanatophoric_dysplasia,type_I,187600/Crouzon_syndrome_with_acanthosis_nigricans,612247/Muenke_syndrome,602849/Bladder_cancer,somatic,109800/Colorectal_cancer,somatic,114500/Cervical_cancer,somatic,603956/LADD_syndrome,149730/CATSHL_syndrome,610474/Nevus,epidermal,somatic,162900/Thanatophoric_dysplasia,type_II,187601/Spermatocytic_seminoma,somatic,273300/SADDAN,616482]
chr4	1986525	1986656	4	7	1	    0.131	0.153	NELFA	0.00023			NELFA	
chr4	1989635	2010972	3	9	4	   21.337	0.076	NELFA	0.00134			NELFA	
chr4	5731024	5735172	3	5	2	    4.148	0.032	EVC	0.00631				604831_[EVC_Ellis-van_Creveld_syndrome,225500/Weyers_acrofacial_dysostosis,193530]
chr4	5754553	5754789	3	3	1	    0.236	0.006	EVC	0.00451				604831_[EVC_Ellis-van_Creveld_syndrome,225500/Weyers_acrofacial_dysostosis,193530]
chr4	6292914	6293104	3	5	1	    0.190	0.064	WFS1	0.00130			WFS1	606201_[WFS1_Wolfram_syndrome_1,222300/Deafness,autosomal_dominant_6/14/38,600965/Wolfram-like_syndrome,autosomal_dominant,614296/Diabetes_mellitus,noninsulin-dependent,association_with,125853/Cataract_41,116400]
chr4	15558917	15559140	1	3	1	    0.223	0.108	CC2D2A	0.00957			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	15591158	15591312	3	4	1	    0.154	0.070	CC2D2A	0.00502			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	17503332	17503492	1	5	1	    0.160	0.032	QDPR	0.00287				612676_[QDPR_Hyperphenylalaninemia,BH4-deficient,C,261630]
chr4	79173536	79176539	1	3	2	    3.003	0.127	FRAS1	0.01866				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79188385	79199908	3	6	2	   11.523	0.134	FRAS1	0.01337				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79254416	79254576	1	3	1	    0.160	0.146	FRAS1	0.01209				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79300870	79305307	1	8	2	    4.437	0.121	FRAS1	0.00155				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79351436	79351581	1	5	1	    0.145	0.115	FRAS1	0.00291				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	88989040	88996121	3	6	2	    7.081	0.070	PKD2	0.00047			PKD2	173910_[PKD2_Polycystic_kidney_disease_2,613095]
chr4	122739189	122739342	3	3	1	    0.153	0.045	CCNA2	0.00659				
chr4	122754376	122754560	1	4	1	    0.184	0.127	BBS7	0.00571				607590_[BBS7_Bardet-Biedl_syndrome_7,615984]
chr4	159627331	159627533	3	5	1	    0.202	0.076	ETFDH	0.00212				231675_[ETFDH_Glutaric_acidemia_IIC,231680]
chr4	184366678	184366828	3	4	1	    0.150	0.096	CDKN2AIP	0.00402				
chr5	1432569	1432823	4	9	1	    0.254	0.140	SLC6A3	0.00001				126455_[SLC6A3_Nicotine_dependence,protection_against,188890/Parkinsonism-dystonia,infantile,1,613135]
chr5	6599342	6604399	3	4	2	    5.057	0.108	NSUN2	0.01886				610916_[NSUN2_Mental_retardation,autosomal_recessive_5,611091]
chr5	10256057	10256275	1	4	1	    0.218	0.121	CCT5	0.00514				610150_[CCT5_Neuropathy,hereditary_sensory,with_spastic_paraplegia,256840]
chr5	35873572	35875699	3	3	3	    2.127	0.032	IL7R	0.02739				146661_[IL7R_Severe_combined_immunodeficiency,T-cell_negative,B-cell/natural_killer_cell-positive_type,608971]
chr5	69359232	70237345	3	5	10	  878.113	0.236	SMN2,SMN1	0.21803	yes	yes	SMN2,SERF1A,SMN1	601627_[SMN2_Spinal_muscular_atrophy,type_III,modifier_of,253400],600354_[SMN1_Spinal_muscular_atrophy-1,253300/Spinal_muscular_atrophy-2,253550/Spinal_muscular_atrophy-3,253400/Spinal_muscular_atrophy-4,271150]
chr5	70892097	70895597	3	7	2	    3.500	0.102	MCCC2	0.00048				609014_[MCCC2_3-Methylcrotonyl-CoA_carboxylase_2_deficiency,210210]
chr5	76640668	76640766	3	5	1	    0.098	0.102	PDE8B	0.00160				603390_[PDE8B_Pigmented_nodular_adrenocortical_disease,primary,3,614190/Striatal_degeneration,autosomal_dominant,609161]
chr5	78111324	78135259	1	4	2	   23.935	0.064	ARSB	0.00996	yes	yes		611542_[ARSB_Mucopolysaccharidosis_type_VI_(Maroteaux-Lamy),253200]
chr5	89981587	89981822	3	3	1	    0.235	0.076	ADGRV1	0.00908			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90006788	90007149	1	3	2	    0.361	0.178	ADGRV1	0.03210			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90012274	90016050	1	6	2	    3.776	0.089	ADGRV1	0.01087			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90072260	90072403	3	4	1	    0.143	0.096	ADGRV1	0.00215			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90149091	90149360	3	4	1	    0.269	0.070	ADGRV1	0.00315			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	127599107	127599358	3	5	1	    0.251	0.121	FBN2	0.00046				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	127638655	127638791	1	3	1	    0.136	0.057	FBN2	0.01520				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	127648316	127653973	3	3	2	    5.657	0.057	FBN2	0.00328				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	131892606	131895069	1	4	2	    2.463	0.089	RAD50	0.02451				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	131915544	131915768	3	5	1	    0.224	0.096	RAD50	0.00072				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	131938982	131939191	3	5	1	    0.209	0.134	RAD50	0.00235				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	131953752	131953996	3	6	1	    0.244	0.121	RAD50	0.00046				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	133945251	133945374	3	4	1	    0.123	0.115	SAR1B	0.01027				607690_[SAR1B_Chylomicron_retention_disease,246700]
chr5	137217652	137217804	3	5	1	    0.152	0.108	MYOT	0.00132				604103_[MYOT_Myopathy,myofibrillar,3,609200/Myopathy,spheroid_body,182920]
chr5	147443525	147443672	1	3	1	    0.147	0.115	SPINK5	0.00656				605010_[SPINK5_Netherton_syndrome,256500]
chr5	147465958	147470801	3	9	4	    4.843	0.089	SPINK5	0.00062				605010_[SPINK5_Netherton_syndrome,256500]
chr5	148388404	148389965	1	4	2	    1.561	0.083	SH3TC2	0.00160				608206_[SH3TC2_Charcot-Marie-Tooth_disease,type_4C,601596/Mononeuropathy_of_the_median_nerve,mild,613353]
chr5	161520824	161520995	3	5	1	    0.171	0.032	GABRG2	0.00253			GABRG2	137164_[GABRG2_Epilepsy,generalized,with_febrile_seizures_plus,type_3,611277/Epilepsy,childhood_absence,susceptibility_to,2,607681/Febrile_seizures,familial,8,611277]
chr5	161569160	161569332	3	5	1	    0.172	0.076	GABRG2	0.00151			GABRG2	137164_[GABRG2_Epilepsy,generalized,with_febrile_seizures_plus,type_3,611277/Epilepsy,childhood_absence,susceptibility_to,2,607681/Febrile_seizures,familial,8,611277]
chr5	176662812	176666876	1	3	3	    4.064	0.051	NSD1	0.04607			NSD1	606681_[NSD1_Sotos_syndrome_1,117550/Leukemia,acute_myeloid,601626]
chr5	176707556	176707845	1	3	1	    0.289	0.076	NSD1	0.00287			NSD1	606681_[NSD1_Sotos_syndrome_1,117550/Leukemia,acute_myeloid,601626]
chr6	7558339	7558507	3	4	1	    0.168	0.089	DSP	0.00339				125647_[DSP_Keratosis_palmoplantaris_striata_II,612908/Cardiomyopathy,dilated,with_woolly_hair_and_keratoderma,605676/Arrhythmogenic_right_ventricular_dysplasia_8,607450/Skin_fragility-woolly_hair_syndrome,607655/Epidermolysis_bullosa,lethal_acantholytic,609638/Dilated_cardiomyopathy_with_woolly_hair,keratoderma,and_tooth_agenesis,615821]
chr6	7576517	7576699	1	3	1	    0.182	0.127	DSP	0.01725				125647_[DSP_Keratosis_palmoplantaris_striata_II,612908/Cardiomyopathy,dilated,with_woolly_hair_and_keratoderma,605676/Arrhythmogenic_right_ventricular_dysplasia_8,607450/Skin_fragility-woolly_hair_syndrome,607655/Epidermolysis_bullosa,lethal_acantholytic,609638/Dilated_cardiomyopathy_with_woolly_hair,keratoderma,and_tooth_agenesis,615821]
chr6	16753454	16761731	3	3	2	    8.277	0.140	ATXN1	0.01100			ATXN1	601556_[ATXN1_Spinocerebellar_ataxia_1,164400]
chr6	24503481	24505223	1	3	2	    1.742	0.159	ALDH5A1	0.07911				610045_[ALDH5A1_Succinic_semialdehyde_dehydrogenase_deficiency,271980]
chr6	31910992	31911314	1	2	2	    0.322	0.064	C2,CFB	0.01284				613927_[C2_C2_deficiency,217000/Macular_degeneration,age-related,14,reduced_risk_of,615489],138470_[CFB_Macular_degeneration,age-related,14,reduced_risk_of,615489/Hemolytic_uremic_syndrome,atypical,susceptibility_to,4,612924/Complement_factor_B_deficiency,615561]
chr6	31964911	31976722	3	3	21	   11.811	0.204	C4A,C4A-AS1,CYP21A1P,TNXA	0.25641	yes	yes	C4A,CYP21A1P	120810_[C4A_C4a_deficiency,614380/Blood_group,Rodgers,614374],600985_[TNXA_Ehlers-Danlos_syndrome,classic-like,1_606408/Vesicoureteral_reflux_8,615963]
chr6	31999318	32003205	3	3	10	    3.887	0.185	C4B,C4B-AS1	0.12517	yes	yes	C4B	120820_[C4B_C4B_deficiency,614379]
chr6	32007313	32008558	3	2	5	    1.245	0.191	CYP21A2	0.11792	yes	yes	CYP21A2	613815_[CYP21A2_Adrenal_hyperplasia,congenital,due_to_21-hydroxylase_deficiency,201910/Hyperandrogenism,nonclassic_type,due_to_21-hydroxylase_deficiency,201910]
chr6	32818087	32818304	1	5	1	    0.217	0.115	PSMB9,TAP1	0.00125				177045_[PSMB9_Proteasome-associated_autoinflammatory_syndrome_3,digenic,617591],170260_[TAP1_Bare_lymphocyte_syndrome,type_I,604571]
chr6	33410656	33411747	3	5	1	    1.091	0.115	SYNGAP1	0.00153			SYNGAP1	603384_[SYNGAP1_Mental_retardation,autosomal_dominant_5,612621]
chr6	33414342	33414573	3	5	1	    0.231	0.153	SYNGAP1	0.00160			SYNGAP1	603384_[SYNGAP1_Mental_retardation,autosomal_dominant_5,612621]
chr6	35427449	35428405	3	3	2	    0.956	0.083	FANCE	0.02093				613976_[FANCE_Fanconi_anemia,complementation_group_E,600901]
chr6	39879998	39880128	1	5	1	    0.130	0.057	MOCS1	0.00062				603707_[MOCS1_Molybdenum_cofactor_deficiency_A,252150]
chr6	49407909	49408076	1	3	1	    0.167	0.083	MMUT	0.00613				609058_[MUT_Methylmalonic_aciduria,mut(0)_type,251000]
chr6	51771003	51771148	1	5	1	    0.145	0.153	PKHD1	0.00335				606702_[PKHD1_Polycystic_kidney_disease_4,with_or_without_hepatic_disease,263200]
chr6	52288475	52288975	1	3	2	    0.500	0.172	EFHC1	0.03100			EFHC1	608815_[EFHC1_Myoclonic_epilepsy,juvenile,susceptibility_to,1,254770/Epilepsy,juvenile_absence,susceptibility_to,1,607631]
chr6	52876825	52878790	3	6	2	    1.965	0.083	ICK	0.00054				612325_[ICK_Endocrine-cerebroosteodysplasia,612651/Epilepsy,juvenile_myoclonic,susceptibility_to,10,617924]
chr6	57059558	57059660	1	4	1	    0.102	0.057	RAB23	0.00307				606144_[RAB23_Carpenter_syndrome,201000]
chr6	88216090	88216176	1	3	1	    0.086	0.038	SLC35A1	0.00303				605634_[SLC35A1_Congenital_disorder_of_glycosylation,type_IIf,603585]
chr6	88224665	88224748	3	4	1	    0.083	0.083	RARS2	0.00187				611524_[RARS2_Pontocerebellar_hypoplasia,type_6,611523]
chr6	100960575	100960804	3	4	1	    0.229	0.057	ASCC3	0.00720				
chr6	102372466	102483451	3	6	3	  110.985	0.038	GRIK2	0.00317	yes		GRIK2	138244_[GRIK2_Mental_retardation,autosomal_recessive,6,611092]
chr6	129371053	129371243	3	4	1	    0.190	0.108	LAMA2	0.00160				156225_[LAMA2_Muscular_dystrophy,limb-girdle,autosomal_recessive_23,618138/Muscular_dystrophy,congenital,merosin_deficient_or_partially_deficient,607855]
chr6	132171120	132171256	3	5	1	    0.136	0.089	ENPP1	0.00168				173335_[ENPP1_Diabetes_mellitus,non-insulin-dependent,susceptibility_to,125853/Obesity,susceptibility_to,601665/Arterial_calcification,generalized,of_infancy,1,208000/Hypophosphatemic_rickets,autosomal_recessive,2,613312/Cole_disease,615522]
chr6	132201010	132201184	3	5	1	    0.174	0.083	ENPP1	0.00112				173335_[ENPP1_Diabetes_mellitus,non-insulin-dependent,susceptibility_to,125853/Obesity,susceptibility_to,601665/Arterial_calcification,generalized,of_infancy,1,208000/Hypophosphatemic_rickets,autosomal_recessive,2,613312/Cole_disease,615522]
chr6	135784253	135787521	3	3	2	    3.268	0.032	AHI1	0.00928			AHI1	608894_[AHI1_Joubert_syndrome_3,608629]
chr6	137147447	137147617	1	5	1	    0.170	0.083	PEX7	0.00303				601757_[PEX7_Rhizomelic_chondrodysplasia_punctata,type_1,215100/Peroxisome_biogenesis_disorder_9B,614879]
chr6	152527293	152527507	1	3	1	    0.214	0.102	SYNE1	0.01027				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152577759	152577910	3	4	1	    0.151	0.025	SYNE1	0.00185				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152599214	152614894	1	9	4	   15.680	0.070	SYNE1	0.00274	yes			608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152631521	152631663	1	3	1	    0.142	0.172	SYNE1	0.01109				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152671293	152671480	1	3	1	    0.187	0.083	SYNE1	0.01219				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152694162	152694364	1	4	1	    0.202	0.076	SYNE1	0.00471				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152777011	152777189	3	5	1	    0.178	0.045	SYNE1	0.00330				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	157517289	157517459	3	6	1	    0.170	0.121	ARID1B	0.00129			ARID1B	614556_[ARID1B_Coffin-Siris_syndrome_1,135900]
chr6	161123215	161123395	1	3	1	    0.180	0.083	PLG	0.00635				173350_[PLG_Dysplasminogenemia,217090/Plasminogen_deficiency,type_I,217090]
chr6	161137667	161139498	1	7	2	    1.831	0.096	PLG	0.00434				173350_[PLG_Dysplasminogenemia,217090/Plasminogen_deficiency,type_I,217090]
chr6	170870869	170871331	5	5	1	    0.462	0.465	TBP	0.00122				600075_[TBP_Spinocerebellar_ataxia_17,607136/Parkinson_disease,susceptibility_to,168600]
chr7	195544	195742	3	3	1	    0.198	0.127	FAM20C	0.00613				611061_[FAM20C_Raine_syndrome,259775]
chr7	42116341	42116466	3	5	1	    0.125	0.089	GLI3	0.00091			GLI3	165240_[GLI3_Greig_cephalopolysyndactyly_syndrome,175700/Pallister-Hall_syndrome,146510/Polydactyly,preaxial,type_IV,174700/Polydactyly,postaxial,types_A1_and_B,174200/Hypothalamic_hamartomas,somatic,241800]
chr7	44191860	44192034	3	4	1	    0.174	0.121	GCK	0.00287				138079_[GCK_MODY,type_II,125851/Diabetes_mellitus,noninsulin-dependent,late_onset,125853/Hyperinsulinemic_hypoglycemia,familial,3,602485/Diabetes_mellitus,permanent_neonatal,606176]
chr7	50547475	50547571	1	4	1	    0.096	0.045	DDC	0.00278				107930_[DDC_Aromatic_L-amino_acid_decarboxylase_deficiency,608643]
chr7	65444704	65444908	3	4	1	    0.204	0.127	GUSB	0.00224				611499_[GUSB_Mucopolysaccharidosis_VII,253220]
chr7	65557534	66098441	1	5	3	  540.907	0.089	ASL,KCTD7	0.00434	yes	yes		608310_[ASL_Argininosuccinic_aciduria,207900],611725_[KCTD7_Epilepsy,progressive_myoclonic_3,with_or_without_intracellular_inclusions,611726]
chr7	73459542	73466179	1	6	3	    6.637	0.134	ELN	0.00851			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	73474206	73477564	3	7	3	    3.358	0.121	ELN,ELN-AS1	0.00289			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	74133188	74133270	3	5	1	    0.082	0.038	GTF2I,STAG3L2	0.00040			GTF2I	
chr7	74144557	74147013	1	3	2	    2.456	0.089	GTF2I,STAG3L2	0.01781			GTF2I	
chr7	75184710	75184865	3	4	1	    0.155	0.140	HIP1	0.00717			HIP1	601767_[HIP1_Prostate_cancer,progression_of,176807]
chr7	75933291	75933624	3	4	1	    0.333	0.076	HSPB1	0.00134				602195_[HSPB1_Neuropathy,distal_hereditary_motor,type_IIB,608634/Charcot-Marie-Tooth_disease,axonal,type_2F,606595]
chr7	87053212	87056246	1	4	2	    3.034	0.108	ABCB4	0.00517				171060_[ABCB4_Cholestasis,progressive_familial_intrahepatic_3,602347/Cholestasis,intrahepatic,of_pregnancy,3,614972/Gallbladder_disease_1,600803]
chr7	87076340	87076531	3	3	1	    0.191	0.115	ABCB4	0.01217				171060_[ABCB4_Cholestasis,progressive_familial_intrahepatic_3,602347/Cholestasis,intrahepatic,of_pregnancy,3,614972/Gallbladder_disease_1,600803]
chr7	114293971	114299497	3	6	3	    5.526	0.083	FOXP2	0.00144			FOXP2	605317_[FOXP2_Speech-language_disorder-1,602081]
chr7	127957702	127957796	1	4	1	    0.094	0.089	RBM28	0.00409				612074_[RBM28_Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079]
chr7	128477442	128477612	3	3	1	    0.170	0.166	FLNC	0.00517	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128480067	128480738	3	7	2	    0.671	0.064	FLNC	0.00023	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128488605	128488781	3	5	1	    0.176	0.121	FLNC	0.00134	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128490847	128491007	3	4	1	    0.160	0.025	FLNC	0.00215	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128492872	128493095	1	5	1	    0.223	0.108	FLNC	0.00303	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128496789	128496985	3	4	1	    0.196	0.070	FLNC	0.00207	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	139813281	139813392	3	4	1	    0.111	0.102	KDM7A	0.00480				
chr7	139829283	139829463	3	5	1	    0.180	0.083	KDM7A	0.00247				
chr7	139838895	139839000	3	4	1	    0.105	0.076	KDM7A	0.00633				
chr7	143029502	143036425	1	10	3	    6.923	0.096	CLCN1	0.00215			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	143039012	143039245	1	3	1	    0.233	0.096	CLCN1	0.01563			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	147092691	147092882	3	3	1	    0.191	0.076	CNTNAP2	0.01323			CNTNAP2	604569_[CNTNAP2_Cortical_dysplasia-focal_epilepsy_syndrome,610042/Autism_susceptibility_15,612100/Pitt-Hopkins_like_syndrome_1,610042]
chr7	147914370	147914626	3	4	1	    0.256	0.045	CNTNAP2	0.00323			CNTNAP2	604569_[CNTNAP2_Cortical_dysplasia-focal_epilepsy_syndrome,610042/Autism_susceptibility_15,612100/Pitt-Hopkins_like_syndrome_1,610042]
chr8	1808053	1812612	3	4	2	    4.559	0.089	ARHGEF10	0.00540				608136_[ARHGEF10_Slowed_nerve_conduction_velocity,AD,608236]
chr8	1857451	1857646	1	4	1	    0.195	0.127	ARHGEF10	0.00360				608136_[ARHGEF10_Slowed_nerve_conduction_velocity,AD,608236]
chr8	6266790	6266901	3	3	1	    0.111	0.146	MCPH1	0.01371				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	6272276	6272414	1	3	1	    0.138	0.127	MCPH1	0.00651				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	6478965	6501150	1	7	2	   22.185	0.057	MCPH1	0.01333				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	22020077	22020255	4	11	1	    0.178	0.121	SFTPC	0.00000				178620_[SFTPC_Surfactant_metabolism_dysfunction,pulmonary,2,610913]
chr8	27637681	27637794	1	3	1	    0.113	0.115	ESCO2	0.00876				609353_[ESCO2_Roberts_syndrome,268300/SC_phocomelia_syndrome,269000]
chr8	38274814	38274944	3	3	1	    0.130	0.210	FGFR1	0.00496			FGFR1	136350_[FGFR1_Pfeiffer_syndrome,101600/Jackson-Weiss_syndrome,123150/Hypogonadotropic_hypogonadism_2_with_or_without_anosmia,147950/Osteoglophonic_dysplasia,166250/Trigonocephaly_1,190440/Hartsfield_syndrome,615465/Encephalocraniocutaneous_lipomatosis,613001]
chr8	38279305	38282227	3	4	2	    2.922	0.159	FGFR1	0.00958			FGFR1	136350_[FGFR1_Pfeiffer_syndrome,101600/Jackson-Weiss_syndrome,123150/Hypogonadotropic_hypogonadism_2_with_or_without_anosmia,147950/Osteoglophonic_dysplasia,166250/Trigonocephaly_1,190440/Hartsfield_syndrome,615465/Encephalocraniocutaneous_lipomatosis,613001]
chr8	38314864	38318783	3	3	2	    3.919	0.064	FGFR1	0.00536			FGFR1	136350_[FGFR1_Pfeiffer_syndrome,101600/Jackson-Weiss_syndrome,123150/Hypogonadotropic_hypogonadism_2_with_or_without_anosmia,147950/Osteoglophonic_dysplasia,166250/Trigonocephaly_1,190440/Hartsfield_syndrome,615465/Encephalocraniocutaneous_lipomatosis,613001]
chr8	43013708	43014197	1	3	2	    0.489	0.102	HGSNAT	0.00649				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	43024306	43024395	1	3	1	    0.089	0.102	HGSNAT	0.01481				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	48690237	48690445	3	4	1	    0.208	0.089	PRKDC	0.00178				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48691279	48691664	1	3	2	    0.385	0.070	PRKDC	0.00253				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48744365	48746967	3	11	2	    2.602	0.076	PRKDC	0.00247				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48775950	48776148	3	3	1	    0.198	0.102	PRKDC	0.00603				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48798495	48798718	1	3	1	    0.223	0.083	PRKDC	0.00984				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48866357	48866489	1	6	1	    0.132	0.038	PRKDC	0.00132				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	75262608	75263711	3	3	2	    1.103	0.166	GDAP1	0.02345				605266_[GDAP1_Charcot-Marie-Tooth_disease,axonal,autosomal_dominant,type_2K,607831],606598_[GDAP1_Charcot-Marie-Tooth_disease,type_4A,214400/Charcot-Marie-Tooth_disease,axonal,with_vocal_cord_paresis,607706/Charcot-Marie-Tooth_disease,axonal,type_2K,607831/Charcot-Marie-Tooth_disease,recessive_intermediate,A,608340]
chr8	94793092	94793220	1	4	1	    0.128	0.076	TMEM67	0.00367				609884_[TMEM67_Meckel_syndrome_3,607361/Joubert_syndrome_6,610688/Bardet-Biedl_syndrome_14,modifier_of,615991/COACH_syndrome,216360/Nephronophthisis_11,613550/RHYNS_syndrome,602152]
chr8	100127918	100128112	3	6	1	    0.194	0.051	VPS13B	0.00198			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	100221810	100286570	1	4	2	   64.760	0.217	VPS13B	0.07630			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	120758935	120768365	1	3	2	    9.430	0.064	TAF2	0.02165				604912_[TAF2_Mental_retardation,autosomal_recessive_40,615599]
chr8	120790249	120793443	1	5	2	    3.194	0.057	TAF2	0.00326				604912_[TAF2_Mental_retardation,autosomal_recessive_40,615599]
chr8	126049469	126049585	3	4	1	    0.116	0.159	WASHC5	0.00373				610657_[WASHC5_Spastic_paraplegia_8,autosomal_dominant,603563/Ritscher-Schinzel_syndrome_1,220210]
chr8	126069788	126069918	3	8	1	    0.130	0.070	WASHC5	0.00010				610657_[WASHC5_Spastic_paraplegia_8,autosomal_dominant,603563/Ritscher-Schinzel_syndrome_1,220210]
chr8	126090970	126094013	3	9	2	    3.043	0.025	WASHC5	0.00249				610657_[WASHC5_Spastic_paraplegia_8,autosomal_dominant,603563/Ritscher-Schinzel_syndrome_1,220210]
chr8	133911033	133911165	1	4	1	    0.132	0.038	TG	0.00112				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	133978795	133980225	1	4	2	    1.430	0.083	TG	0.00006				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	134108440	134108627	3	5	1	    0.187	0.064	SLA,TG	0.00130				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	134125656	134125857	1	6	1	    0.201	0.096	TG	0.00021				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	134262673	134269116	3	5	2	    6.443	0.096	NDRG1	0.00508				605262_[NDRG1_Charcot-Marie-Tooth_disease,type_4D,601455]
chr8	134296482	134296582	3	7	1	    0.100	0.121	NDRG1	0.00060				605262_[NDRG1_Charcot-Marie-Tooth_disease,type_4D,601455]
chr8	140742576	140743481	3	4	1	    0.905	0.146	TRAPPC9	0.00151				611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	140744212	140999054	1	3	4	  254.842	0.134	TRAPPC9	0.04945	yes			611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	141301082	141310723	3	6	2	    9.641	0.108	TRAPPC9	0.01927				611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	143957647	143958311	3	5	2	    0.664	0.146	CYP11B1	0.01316	yes		CYP11B1	610613_[CYP11B1_Adrenal_hyperplasia,congenital,due_to_11-beta-hydroxylase_deficiency,202010/Aldosteronism,glucocorticoid-remediable,103900]
chr8	143991965	143996334	3	5	6	    4.369	0.083	CYP11B2	0.01213	yes		CYP11B2	124080_[CYP11B2_Hypoaldosteronism,congenital,due_to_CMO_II_deficiency,610600/Hypoaldosteronism,congenital,due_to_CMO_I_deficiency,203400/Low_renin_hypertension,susceptibility_to/Aldosterone_to_renin_ratio_raised]
chr8	144989311	144996573	3	3	1	    7.262	0.153	PLEC	0.02025				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr8	145008968	145011249	3	1	5	    2.281	0.185	PLEC	0.14466				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr9	289500	304714	1	4	2	   15.214	0.121	DOCK8	0.02307	yes			611432_[DOCK8_Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700]
chr9	439235	439398	1	3	1	    0.163	0.115	DOCK8	0.00923				611432_[DOCK8_Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700]
chr9	731148	732627	3	3	2	    1.479	0.115	KANK1	0.01233			KANK1	607704_[KANK1_Cerebral_palsy,spastic_quadriplegic,2,612900]
chr9	2103993	2104179	3	4	1	    0.186	0.064	SMARCA2	0.00249				600014_[SMARCA2_Nicolaides-Baraitser_syndrome,601358]
chr9	2635443	2635582	3	6	1	    0.139	0.057	VLDLR	0.00047				192977_[VLDLR_Cerebellar_hypoplasia_and_mental_retardation_with_or_without_quadrupedal_locomotion_1,224050]
chr9	34647076	34647265	1	4	1	    0.189	0.127	GALT	0.00561				606999_[GALT_Galactosemia,230400]
chr9	34648321	34648463	1	3	1	    0.142	0.134	GALT	0.01093				606999_[GALT_Galactosemia,230400]
chr9	35062965	35064292	3	5	2	    1.327	0.070	VCP	0.00012				601023_[VCP_Inclusion_body_myopathy_with_early-onset_Paget_disease_and_frontotemporal_dementia_1,167320/Amyotrophic_lateral_sclerosis_14,with_or_without_frontotemporal_dementia,613954/Charcot-Marie-Tooth_disease,type_2Y,616687]
chr9	35682913	35683248	3	3	1	    0.335	0.102	TPM2	0.01756				190990_[TPM2_Arthrogryposis_multiplex_congenita,distal,type_1,108120/Arthrogryposis,distal,type_2B,601680/Nemaline_myopathy_4,autosomal_dominant,609285/CAP_myopathy_2,609285]
chr9	71668046	71668186	1	5	1	    0.140	0.083	FXN	0.00188				606829_[FXN_Friedreich_ataxia,229300/Friedreich_ataxia_with_retained_reflexes,229300]
chr9	79865003	79865155	3	7	1	    0.152	0.108	VPS13A	0.00037				605978_[VPS13A_Choreoacanthocytosis,200150]
chr9	79874992	79888290	1	5	2	   13.298	0.025	VPS13A	0.00985				605978_[VPS13A_Choreoacanthocytosis,200150]
chr9	94118360	94118447	3	3	1	    0.087	0.070	AUH	0.01093				600529_[AUH_3-methylglutaconic_aciduria,type_I,250950]
chr9	94809885	94810000	1	4	1	    0.115	0.108	SPTLC1	0.01375				605712_[SPTLC1_Neuropathy,hereditary_sensory_and_autonomic,type_IA,162400]
chr9	97869338	97869561	3	3	1	    0.223	0.038	FANCC	0.00649				613899_[FANCC_Fanconi_anemia,complementation_group_C,227645]
chr9	98212113	98218705	3	4	3	    6.592	0.032	PTCH1	0.02007			PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	98238306	98238451	1	6	1	    0.145	0.064	PTCH1	0.00134			PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	98241272	98242382	3	7	2	    1.110	0.076	PTCH1	0.00012			PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	98244221	98268891	3	5	4	   24.670	0.076	PTCH1	0.03785	yes		PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	100451806	100451931	3	4	1	    0.125	0.115	XPA	0.00321				611153_[XPA_Xeroderma_pigmentosum,group_A,278700]
chr9	111641716	111641847	3	6	1	    0.131	0.083	ELP1	0.00056				603722_[ELP1_Dysautonomia,familial,223900]
chr9	111665833	111665959	3	4	1	    0.126	0.083	ELP1	0.00125				603722_[ELP1_Dysautonomia,familial,223900]
chr9	111692039	111693491	1	4	2	    1.452	0.134	ELP1	0.04716				603722_[ELP1_Dysautonomia,familial,223900]
chr9	113547085	113547306	3	3	1	    0.221	0.064	MUSK	0.00330				601296_[MUSK_Myasthenic_syndrome,congenital,9,associated_with_acetylcholine_receptor_deficiency,616325/Fetal_akinesia_deformation_sequence,208150]
chr9	113562576	115983968	3	4	2	 2421.392	0.070	MUSK,SLC31A1	0.00743	yes	yes		601296_[MUSK_Myasthenic_syndrome,congenital,9,associated_with_acetylcholine_receptor_deficiency,616325/Fetal_akinesia_deformation_sequence,208150]
chr9	116019383	116019475	3	5	1	    0.092	0.121	SLC31A1	0.00224				
chr9	123719553	123719656	3	3	1	    0.103	0.051	C5	0.00625				120900_[C5_C5_deficiency,609536/Eculizumab,poor_response_to,615749]
chr9	123797071	123800239	1	5	2	    3.168	0.083	C5	0.00958				120900_[C5_C5_deficiency,609536/Eculizumab,poor_response_to,615749]
chr9	131371143	131371266	1	3	1	    0.123	0.076	SPTAN1	0.00268				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	131374378	131374535	3	5	1	    0.157	0.051	SPTAN1	0.00198				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	131707799	131710022	3	3	1	    2.223	0.038	DOLK,NUP188	0.00028				610746_[DOLK_Congenital_disorder_of_glycosylation,type_Im,610768]
chr9	133370244	133370420	3	3	1	    0.176	0.076	ASS1	0.00942				603470_[ASS1_Citrullinemia,215700]
chr9	134384288	134385205	3	3	2	    0.917	0.096	POMT1	0.03322			POMT1	607423_[POMT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,1,236670/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,1,613155/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,1,609308]
chr9	134386714	134386864	1	3	1	    0.150	0.045	POMT1	0.01531			POMT1	607423_[POMT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,1,236670/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,1,613155/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,1,609308]
chr9	134397424	134397621	3	5	1	    0.197	0.121	POMT1	0.00287			POMT1	607423_[POMT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,1,236670/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,1,613155/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,1,609308]
chr9	135161800	135163748	1	3	2	    1.948	0.083	SETX	0.01419				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	135206654	135211912	3	8	3	    5.258	0.057	SETX	0.00134				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	135782678	135782767	4	4	1	    0.089	0.166	TSC1	0.00710			TSC1	605284_[TSC1_Tuberous_sclerosis-1,191100/Lymphangioleiomyomatosis,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr9	135798725	135798889	3	5	1	    0.164	0.083	TSC1	0.00434			TSC1	605284_[TSC1_Tuberous_sclerosis-1,191100/Lymphangioleiomyomatosis,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr9	136287110	136287678	3	7	1	    0.568	0.102	ADAMTS13	0.00014				604134_[ADAMTS13_Thrombotic_thrombocytopenic_purpura,familial,274150]
chr9	136409582	136412345	3	6	2	    2.763	0.146	ADAMTSL2	0.00689				612277_[ADAMTSL2_Geleophysic_dysplasia_1,231050]
chr9	139264192	139265163	1	2	3	    0.971	0.108	CARD9	0.01434				607212_[CARD9_Candidiasis,familial,2,autosomal_recessive,212050]
chr9	139323057	139327741	3	4	7	    4.684	0.127	INPP5E	0.08368				613037_[INPP5E_Mental_retardation,truncal_obesity,retinal_dystrophy,and_micropenis,610156/Joubert_syndrome_1,213300]
chr9	139723835	139723946	3	4	1	    0.111	0.217	RABL6	0.00730				
chr9	139730184	139732477	3	6	2	    2.293	0.172	RABL6	0.00862				
chr9	139734764	139982645	4	4	3	  247.881	0.108	RABL6,MAN1B1	0.02747	yes			604346_[MAN1B1_Mental_retardation,autosomal_recessive_15,614202]
chr9	140001692	140001909	3	5	1	    0.217	0.089	MAN1B1	0.00215				604346_[MAN1B1_Mental_retardation,autosomal_recessive_15,614202]
chr9	140646773	140646870	4	6	1	    0.097	0.096	EHMT1	0.00042			EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr9	140712502	140728986	3	3	2	   16.484	0.217	EHMT1	0.09169	yes		EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr10	14977452	14977573	1	3	1	    0.121	0.146	DCLRE1C	0.01149				605988_[DCLRE1C_Severe_combined_immunodeficiency,Athabascan_type,602450/Omenn_syndrome,603554]
chr10	43609918	43610194	3	5	1	    0.276	0.083	RET	0.00229			RET	164761_[RET_Multiple_endocrine_neoplasia_IIA,171400/Medullary_thyroid_carcinoma,155240/Multiple_endocrine_neoplasia_IIB,162300/Central_hypoventilation_syndrome,congenital,209880/Pheochromocytoma,171300/Hirschsprung_disease,susceptibility_to,1,142623/Hirschsprung_disease,protection_against,142623]
chr10	50691382	50691572	3	4	1	    0.190	0.051	ERCC6	0.00488				609413_[ERCC6_Cockayne_syndrome,type_B,133540/Cerebrooculofacioskeletal_syndrome_1,214150/De_Sanctis-Cacchione_syndrome,278800/Macular_degeneration,age-related,susceptibility_to,5,613761/UV-sensitive_syndrome_1,600630/Lung_cancer,susceptibility_to,211980/Premature_ovarian_failure_11,616946]
chr10	73269829	73269991	3	5	1	    0.162	0.134	CDH23,CDH23-AS1	0.00100				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73439134	73442339	3	3	2	    3.205	0.172	CDH23	0.07889				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73491734	73492491	3	3	1	    0.757	0.083	C10ORF105,CDH23	0.00442				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73569567	73569843	3	4	1	    0.276	0.096	CDH23	0.00603				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	82034763	82036360	1	9	2	    1.597	0.115	MAT1A	0.00109				610550_[MAT1A_Hypermethioninemia,persistent,autosomal_dominant,due_to_methionine_adenosyltransferase_I/III_deficiency,250850/Methionine_adenosyltransferase_deficiency,autosomal_recessive,250850]
chr10	83635060	83635929	4	3	1	    0.869	0.166	NRG3	0.00985			NRG3	
chr10	88478474	88486019	1	8	2	    7.545	0.057	LDB3	0.00134				605906_[LDB3_Myopathy,myofibrillar,4,609452/Cardiomyopathy,dilated,1C,with_or_without_LVNC,601493/Cardiomyopathy,hypertrophic,24,601493/Left_ventricular_noncompaction_3,601493]
chr10	96039529	96043678	3	3	2	    4.149	0.127	PLCE1,PLCE1-AS1	0.02579				608414_[PLCE1_Nephrotic_syndrome,type_3,610725]
chr10	97396840	97397203	1	0	2	    0.363	0.115	ALDH18A1	0.00268				138250_[ALDH18A1_Cutis_laxa,autosomal_recessive,type_IIIA,219150/Spastic_paraplegia_9A,autosomal_dominant,601162/Spastic_paraplegia_9B,autosomal_recessive,616586/Cutis_laxa,autosomal_dominant_3,616603]
chr10	104592258	104592447	3	4	1	    0.189	0.051	CYP17A1	0.00176				609300_[CYP17A1_17-alpha-hydroxylase/17,20-lyase_deficiency,202110/17,20-lyase_deficiency,isolated,202110]
chr10	105796240	105796400	1	6	1	    0.160	0.064	COL17A1	0.00048				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	105822006	105836197	3	8	4	   14.191	0.089	COL17A1	0.00100				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	112328686	112337260	1	7	3	    8.574	0.025	SMC3	0.00807				606062_[SMC3_Cornelia_de_Lange_syndrome_3,610759]
chr10	121431757	121432178	3	6	1	    0.421	0.089	BAG3	0.00046			BAG3	603883_[BAG3_Myopathy,myofibrillar,6,612954/Cardiomyopathy,dilated,1HH,613881]
chr10	123247495	123247637	3	4	1	    0.142	0.178	FGFR2	0.00612			FGFR2	176943_[FGFR2_Crouzon_syndrome,123500/Jackson-Weiss_syndrome,123150/Beare-Stevenson_cutis_gyrata_syndrome,123790/Pfeiffer_syndrome,101600/Apert_syndrome,101200/Saethre-Chotzen_syndrome,101400/Craniosynostosis,nonspecific/Gastric_cancer,somatic,613659/Craniofacial-skeletal-dermatologic_dysplasia,101600/Antley-Bixler_syndrome_without_genital_anomalies_or_disordered_steroidogenesis,207410/Scaphocephaly_and_Axenfeld-Rieger_anomaly/LADD_syndrome,149730/Scaphocephaly,maxillary_retrusion,and_mental_retardation,609579/Bent_bone_dysplasia_syndrome,614592]
chr11	1773972	1774910	3	5	1	    0.938	0.089	CTSD	0.00185				116840_[CTSD_Ceroid_lipofuscinosis,neuronal,10,610127]
chr11	1778544	1780879	3	6	3	    2.335	0.159	CTSD	0.02011				116840_[CTSD_Ceroid_lipofuscinosis,neuronal,10,610127]
chr11	2415315	2415432	1	6	1	    0.117	0.076	CD81	0.00042				186845_[CD81_Immunodeficiency,common_variable,6,613496]
chr11	2417089	2417954	3	3	2	    0.865	0.261	CD81	0.06228				186845_[CD81_Immunodeficiency,common_variable,6,613496]
chr11	6637536	6638394	1	3	3	    0.858	0.140	TPP1	0.00405				607998_[TPP1_Ceroid_lipofuscinosis,neuronal,2,204500/Spinocerebellar_ataxia,autosomal_recessive_7,609270]
chr11	17406786	17415316	3	3	3	    8.530	0.083	KCNJ11,ABCC8	0.01439			KCNJ11,ABCC8	600937_[KCNJ11_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17416709	17416832	1	4	1	    0.123	0.089	ABCC8	0.00158			ABCC8	600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17450102	17464439	1	4	3	   14.337	0.096	ABCC8	0.06821			ABCC8	600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17491638	17496584	3	3	2	    4.946	0.051	ABCC8	0.00264			ABCC8	600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17538938	17539031	1	4	1	    0.093	0.083	USH1C	0.00268			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	22214712	22215088	3	6	1	    0.376	0.083	ANO5	0.00056				608662_[ANO5_Gnathodiaphyseal_dysplasia,166260/Muscular_dystrophy,limb-girdle,autosomal_recessive_12,611307/Miyoshi_muscular_dystrophy_3,613319]
chr11	22261105	22261240	3	9	1	    0.135	0.025	ANO5	0.00005				608662_[ANO5_Gnathodiaphyseal_dysplasia,166260/Muscular_dystrophy,limb-girdle,autosomal_recessive_12,611307/Miyoshi_muscular_dystrophy_3,613319]
chr11	31822229	31822414	3	5	1	    0.185	0.089	PAX6	0.00155			PAX6	607108_[PAX6_Aniridia,106210/Cataract_with_late-onset_corneal_dystrophy,106210/Anterior_segment_dysgenesis_5,multiple_subtypes,604229/Foveal_hypoplasia_1,136520/Keratitis,148190/Optic_nerve_hypoplasia,165550/Morning_glory_disc_anomaly,120430/Coloboma_of_optic_nerve,120430/Coloboma,ocular,120200],606985_[PAX6_Aniridia_2,617141]
chr11	36589553	36589682	3	5	1	    0.129	0.108	RAG1	0.00335				179615_[RAG1_Severe_combined_immunodeficiency,B_cell-negative,601457/Omenn_syndrome,603554/Alpha/beta_T-cell_lymphopenia_with_gamma/delta_T-cell_expansion,severe_cytomegalovirus_infection,and_autoimmunity,609889/Combined_cellular_and_humoral_immune_defects_with_granulomas,233650]
chr11	61165236	61165457	1	4	1	    0.221	0.140	TMEM216	0.00371				613277_[TMEM216_Joubert_syndrome_2,608091/Meckel_syndrome_2,603194]
chr11	62457724	62458003	1	3	1	    0.279	0.108	BSCL2,HNRNPUL2-BSCL2	0.00875				606158_[BSCL2_Lipodystrophy,congenital_generalized,type_2,269700/Silver_spastic_paraplegia_syndrome,270685/Neuropathy,distal_hereditary_motor,type_VA,600794/Encephalopathy,progressive,with_or_without_lipodystrophy,615924]
chr11	62460125	62460279	1	4	1	    0.154	0.076	BSCL2,HNRNPUL2-BSCL2	0.00287				606158_[BSCL2_Lipodystrophy,congenital_generalized,type_2,269700/Silver_spastic_paraplegia_syndrome,270685/Neuropathy,distal_hereditary_motor,type_VA,600794/Encephalopathy,progressive,with_or_without_lipodystrophy,615924]
chr11	63986713	63986840	4	4	1	    0.127	0.185	FERMT3	0.00651				607901_[FERMT3_Leukocyte_adhesion_deficiency,type_III,612840]
chr11	65638618	65639842	3	7	2	    1.224	0.102	EFEMP2	0.00015				604633_[EFEMP2_Cutis_laxa,autosomal_recessive,type_IB,614437]
chr11	66298355	66298509	3	7	1	    0.154	0.121	BBS1,ZDHHC24	0.00010				209901_[BBS1_Bardet-Biedl_syndrome_1,209900]
chr11	66459997	66460581	1	3	2	    0.584	0.108	SPTBN2	0.00665				604985_[SPTBN2_Spinocerebellar_ataxia_5,600224/Spinocerebellar_ataxia,autosomal_recessive_14,615386]
chr11	66638513	66638678	1	3	1	    0.165	0.172	PC	0.00496				608786_[PC_Pyruvate_carboxylase_deficiency,266150]
chr11	67374313	67375959	3	4	2	    1.646	0.089	NDUFV1	0.00649			NDUFV1	161015_[NDUFV1_Mitochondrial_complex_I_deficiency,nuclear_type_4,618225]
chr11	67765819	67765932	3	4	1	    0.113	0.217	UNC93B1	0.00290				608204_[UNC93B1_Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67815104	67816771	3	4	4	    1.667	0.115	TCIRG1	0.03653				604592_[TCIRG1_Osteopetrosis,autosomal_recessive_1,259700]
chr11	68115305	68125325	3	7	2	   10.020	0.108	LRP5	0.00110				603506_[LRP5_Osteoporosis-pseudoglioma_syndrome,259770/Bone_mineral_density_variability_1,601884/Hyperostosis,endosteal,144750/van_Buchem_disease,type_2,607636/Osteosclerosis,144750/Osteoporosis,166710/Exudative_vitreoretinopathy_4,601813/Osteopetrosis,autosomal_dominant_1,607634/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875]
chr11	68207235	68207394	1	4	1	    0.159	0.096	LRP5	0.00156				603506_[LRP5_Osteoporosis-pseudoglioma_syndrome,259770/Bone_mineral_density_variability_1,601884/Hyperostosis,endosteal,144750/van_Buchem_disease,type_2,607636/Osteosclerosis,144750/Osteoporosis,166710/Exudative_vitreoretinopathy_4,601813/Osteopetrosis,autosomal_dominant_1,607634/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875]
chr11	68527027	68527816	3	5	2	    0.789	0.057	CPT1A	0.00517				600528_[CPT1A_CPT_deficiency,hepatic,type_IA,255120]
chr11	68542774	68548223	1	3	2	    5.449	0.115	CPT1A	0.03377	yes			600528_[CPT1A_CPT_deficiency,hepatic,type_IA,255120]
chr11	68682281	68696835	1	5	3	   14.554	0.083	IGHMBP2	0.00758				600502_[IGHMBP2_Neuronopathy,distal_hereditary_motor,type_VI,604320/Charcot-Marie-Tooth_disease,axonal,type_2S,616155]
chr11	70338430	70348401	3	4	2	    9.971	0.134	SHANK2	0.00202			SHANK2	603290_[SHANK2_Autism_susceptibility_17,613436]
chr11	70544783	70653286	3	13	3	  108.503	0.076	SHANK2	0.00162			SHANK2	603290_[SHANK2_Autism_susceptibility_17,613436]
chr11	70829865	70830088	3	9	1	    0.223	0.057	SHANK2	0.00007			SHANK2	603290_[SHANK2_Autism_susceptibility_17,613436]
chr11	71152263	71153409	3	6	2	    1.146	0.089	DHCR7	0.00022			DHCR7	602858_[DHCR7_Smith-Lemli-Opitz_syndrome,270400]
chr11	76839300	76839545	3	5	1	    0.245	0.121	MYO7A	0.00212				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76892987	76896051	3	4	4	    3.064	0.102	MYO7A	0.00519				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76908516	76910873	3	3	3	    2.357	0.064	MYO7A	0.00930				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76917132	76917257	3	3	1	    0.125	0.204	MYO7A	0.01315				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	88068095	88068260	1	3	1	    0.165	0.089	CTSC	0.00792				602365_[CTSC_Papillon-Lefevre_syndrome,245000/Haim-Munk_syndrome,245010/Periodontitis_1,juvenile,170650]
chr11	103182597	103187359	1	4	2	    4.762	0.076	DYNC2H1	0.03497				603297_[DYNC2H1_Short-rib_thoracic_dysplasia_3_with_or_without_polydactyly,613091]
chr11	108014700	108014784	1	4	1	    0.084	0.089	ACAT1	0.00256				607809_[ACAT1_Alpha-methylacetoacetic_aciduria,203750]
chr11	108154944	108158452	1	4	2	    3.508	0.019	ATM	0.01837				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	108168004	108168119	3	4	1	    0.115	0.032	ATM	0.00303				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	108178614	108178721	3	3	1	    0.107	0.127	ATM	0.01051				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	118183323	118183591	3	4	1	    0.268	0.076	CD3E	0.00283				186830_[CD3E_Immunodeficiency_18,615615/Immunodeficiency_18,SCID_variant,615615]
chr11	118895891	118896049	1	3	1	    0.158	0.146	SLC37A4,TRAPPC4	0.01078				602671_[SLC37A4_Glycogen_storage_disease_Ib,232220/Glycogen_storage_disease_Ic,232240]
chr11	119213573	119213723	1	4	1	    0.150	0.057	C1QTNF5,MFRP	0.00148				606227_[MFRP_Microphthalmia,isolated_5,611040/Nanophthalmos_2,609549],608752_[C1QTNF5_Retinal_degeneration,late-onset,autosomal_dominant,605670]
chr11	121175060	121175212	1	5	1	    0.152	0.070	SC5D	0.00093				602286_[SC5D_Lathosterolosis,607330]
chr11	126138925	126139196	3	4	1	    0.271	0.146	FOXRED1	0.00330				613622_[FOXRED1_Mitochondrial_complex_I_deficiency,nuclear_type_19,618241]
chr11	126306696	126315010	3	11	2	    8.314	0.108	KIRREL3	0.00048				
chr12	416102	416265	3	4	1	    0.163	0.057	KDM5A	0.00509				
chr12	971239	971446	3	8	1	    0.207	0.089	WNK1	0.00008				605232_[WNK1_Pseudohypoaldosteronism,type_IIC,614492/Neuropathy,hereditary_sensory_and_autonomic,type_II,201300]
chr12	987368	987537	1	4	1	    0.169	0.108	WNK1	0.00795				605232_[WNK1_Pseudohypoaldosteronism,type_IIC,614492/Neuropathy,hereditary_sensory_and_autonomic,type_II,201300]
chr12	5019063	5019648	4	8	1	    0.585	0.140	KCNA1	0.00006			KCNA1	176260_[KCNA1_Episodic_ataxia/myokymia_syndrome,160120]
chr12	7044700	7046734	4	4	1	    2.034	0.159	ATN1	0.00122				607462_[ATN1_Dentatorubro-pallidoluysian_atrophy,125370]
chr12	7054924	7168191	1	3	2	  113.267	0.127	C12ORF57,C1S	0.03958				615140_[C12ORF57_Temtamy_syndrome,218340],611531_[EMG1_Bowen-Conradi_syndrome,211180],120580_[C1S_C1s_deficiency,613783/Ehlers-Danlos_syndrome,periodontal_type,2,617174]
chr12	7241879	7242339	1	3	2	    0.460	0.102	C1R	0.02347				613785_[C1R_Ehlers-Danlos_syndrome,periodontal_type,1,130080]
chr12	7361591	7361776	3	4	1	    0.185	0.121	PEX5	0.00304				600414_[PEX5_Peroxisome_biogenesis_disorder_2A_(Zellweger),214110/Peroxisome_biogenesis_disorder_2B,202370/Rhizomelic_chondrodysplasia_punctata,type_5,616716]
chr12	31237893	31238070	1	6	1	    0.177	0.102	DDX11	0.00096	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	31253559	31253651	3	3	1	    0.092	0.115	DDX11	0.00883	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	31254757	31254926	1	4	1	    0.169	0.057	DDX11	0.00323	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	41331362	41331499	3	5	1	    0.137	0.089	CNTN1	0.00214				600016_[CNTN1_Myopathy,congenital,Compton-North,612540]
chr12	44177455	44177537	1	5	1	    0.082	0.064	IRAK4	0.00119				606883_[IRAK4_IRAK4_deficiency,607676/Invasive_pneumococcal_disease,recurrent_isolated,1,610799]
chr12	48293610	48293751	3	6	1	    0.141	0.076	VDR	0.00034				601769_[VDR_Rickets,vitamin_D-resistant,type_IIA,277440/Osteoporosis,involutional,166710]
chr12	49421576	49421934	1	1	2	    0.358	0.076	KMT2D	0.00938			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49435862	49436438	1	4	2	    0.576	0.102	KMT2D	0.01315			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49448301	49448819	1	3	2	    0.518	0.140	KMT2D	0.02481			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	51130809	51130903	1	5	1	    0.094	0.096	DIP2B	0.00122				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	51135189	51135332	3	5	1	    0.143	0.057	DIP2B	0.00164				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	56090990	56091071	1	3	1	    0.081	0.064	ITGA7	0.00407				600536_[ITGA7_Muscular_dystrophy,congenital,due_to_ITGA7_deficiency,613204]
chr12	56491559	56491734	3	5	1	    0.175	0.070	ERBB3	0.00144				190151_[ERBB3_Lethal_congenital_contractural_syndrome_2,607598/Erythroleukemia,familial,susceptibility_to,133180]
chr12	57965834	57966519	3	4	2	    0.685	0.083	KIF5A	0.00158				602821_[KIF5A_Spastic_paraplegia_10,autosomal_dominant,604187/Myoclonus,intractable,neonatal,617235/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921]
chr12	57970534	57970655	1	3	1	    0.121	0.051	KIF5A	0.00158				602821_[KIF5A_Spastic_paraplegia_10,autosomal_dominant,604187/Myoclonus,intractable,neonatal,617235/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921]
chr12	65122726	65122847	3	6	1	    0.121	0.089	GNS	0.00095				607664_[GNS_Mucopolysaccharidosis_type_IIID,252940]
chr12	66932848	66933013	3	3	1	    0.165	0.057	GRIP1	0.00792			GRIP1	604597_[GRIP1_Fraser_syndrome_3,617667]
chr12	88456459	88456565	3	4	1	    0.106	0.045	CEP290	0.00312			CEP290	610142_[CEP290_Joubert_syndrome_5,610188/Senior-Loken_syndrome_6,610189/Leber_congenital_amaurosis_10,611755/Meckel_syndrome_4,611134/Bardet-Biedl_syndrome_14,615991]
chr12	88487537	88487762	3	4	1	    0.225	0.102	CEP290	0.00150			CEP290	610142_[CEP290_Joubert_syndrome_5,610188/Senior-Loken_syndrome_6,610189/Leber_congenital_amaurosis_10,611755/Meckel_syndrome_4,611134/Bardet-Biedl_syndrome_14,615991]
chr12	102147140	102147327	3	4	1	    0.187	0.083	GNPTAB	0.00448				607840_[GNPTAB_Mucolipidosis_III_alpha/beta,252600/Mucolipidosis_II_alpha/beta,252500]
chr12	102155332	102155551	3	4	1	    0.219	0.045	GNPTAB	0.00375				607840_[GNPTAB_Mucolipidosis_III_alpha/beta,252600/Mucolipidosis_II_alpha/beta,252500]
chr12	106826086	106826268	3	7	1	    0.182	0.115	POLR3B	0.00100				614366_[POLR3B_Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381]
chr12	106897849	106898042	3	5	1	    0.193	0.102	POLR3B	0.00151				614366_[POLR3B_Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381]
chr12	110029036	110029172	3	5	1	    0.136	0.083	MVK	0.00132				251170_[MVK_Mevalonic_aciduria,610377/Hyper-IgD_syndrome,260920/Porokeratosis_3,multiple_types,175900]
chr12	110220882	110222252	3	11	2	    1.370	0.108	TRPV4	0.00011				605427_[TRPV4_Brachyolmia_type_3,113500/Spondylometaphyseal_dysplasia,Kozlowski_type,184252/Metatropic_dysplasia,156530/Hereditary_motor_and_sensory_neuropathy,type_IIc,606071/Scapuloperoneal_spinal_muscular_atrophy,181405/Sodium_serum_level_QTL_1,613508/Parastremmatic_dwarfism,168400/SED,Maroteaux_type,184095/Spinal_muscular_atrophy,distal,congenital_nonprogressive,600175/Digital_arthropathy-brachydactyly,familial,606835/Avascular_necrosis_of_femoral_head,primary,2,617383]
chr12	110236409	110238573	3	5	2	    2.164	0.076	TRPV4	0.00462				605427_[TRPV4_Brachyolmia_type_3,113500/Spondylometaphyseal_dysplasia,Kozlowski_type,184252/Metatropic_dysplasia,156530/Hereditary_motor_and_sensory_neuropathy,type_IIc,606071/Scapuloperoneal_spinal_muscular_atrophy,181405/Sodium_serum_level_QTL_1,613508/Parastremmatic_dwarfism,168400/SED,Maroteaux_type,184095/Spinal_muscular_atrophy,distal,congenital_nonprogressive,600175/Digital_arthropathy-brachydactyly,familial,606835/Avascular_necrosis_of_femoral_head,primary,2,617383]
chr12	110781027	110782786	1	6	2	    1.759	0.153	ATP2A2	0.02163				108740_[ATP2A2_Darier_disease,124200/Acrokeratosis_verruciformis,101900]
chr12	111893823	111908054	3	11	2	   14.231	0.076	ATXN2	0.00001				601517_[ATXN2_Spinocerebellar_ataxia_2,183090/Amyotrophic_lateral_sclerosis,susceptibility_to,13,183090/Parkinson_disease,late-onset,susceptibility_to,168600]
chr12	116421975	116422187	3	8	1	    0.212	0.096	MED13L	0.00010			MED13L	608771_[MED13L_Transposition_of_the_great_arteries,dextro-looped_1,608808/Mental_retardation_and_distinctive_facial_features_with_or_without_cardiac_defects,616789]
chr12	121426626	121434226	3	8	4	    7.600	0.070	HNF1A	0.00033				142410_[HNF1A_MODY,type_III,600496/Diabetes_mellitus,noninsulin-dependent,2,125853/Diabetes_mellitus,insulin-dependent,222100/Hepatic_adenoma,somatic,142330/Renal_cell_carcinoma,144700/Diabetes_mellitus,insulin-dependent,20,612520]
chr12	121437061	121437202	3	4	1	    0.141	0.070	HNF1A	0.00953				142410_[HNF1A_MODY,type_III,600496/Diabetes_mellitus,noninsulin-dependent,2,125853/Diabetes_mellitus,insulin-dependent,222100/Hepatic_adenoma,somatic,142330/Renal_cell_carcinoma,144700/Diabetes_mellitus,insulin-dependent,20,612520]
chr12	122801286	122801412	1	5	1	    0.126	0.115	CLIP1	0.00204				
chr12	124109324	124111050	3	5	2	    1.726	0.045	EIF2B1	0.01681				606686_[EIF2B1_Leukoencephalopathy_with_vanishing_white_matter,603896]
chr12	124228738	124228894	3	3	1	    0.156	0.115	ATP6V0A2	0.00915				611716_[ATP6V0A2_Cutis_laxa,autosomal_recessive,type_IIA,219200/Wrinkly_skin_syndrome,278250]
chr12	124236820	124239094	3	7	2	    2.274	0.070	ATP6V0A2	0.00473	yes			611716_[ATP6V0A2_Cutis_laxa,autosomal_recessive,type_IIA,219200/Wrinkly_skin_syndrome,278250]
chr12	132425827	132426538	3	5	1	    0.711	0.083	PUS1	0.00215				608109_[PUS1_Myopathy,lactic_acidosis,and_sideroblastic_anemia_1,600462]
chr13	32731400	32731552	3	5	1	    0.152	0.051	FRY	0.00149				
chr13	32760387	32760567	3	3	1	    0.180	0.083	FRY	0.00208				
chr13	32802583	32802801	1	4	1	    0.218	0.134	FRY	0.00323				
chr13	32808701	32808908	1	5	1	    0.207	0.019	FRY	0.00144				
chr13	32839577	32839763	3	5	1	    0.186	0.064	FRY	0.00092				
chr13	39424165	39425255	1	5	2	    1.090	0.146	FREM2	0.01444				608945_[FREM2_Fraser_syndrome_2,617666]
chr13	39432002	39432180	3	5	1	    0.178	0.089	FREM2	0.00150				608945_[FREM2_Fraser_syndrome_2,617666]
chr13	51522113	51528131	3	3	2	    6.018	0.134	RNASEH2B	0.01419				610326_[RNASEH2B_Aicardi-Goutieres_syndrome_2,610181]
chr13	52513177	52515370	1	4	2	    2.193	0.134	ATP7B	0.04607				606882_[ATP7B_Wilson_disease,277900]
chr13	52531642	52532690	3	3	2	    1.048	0.070	ATP7B	0.00716				606882_[ATP7B_Wilson_disease,277900]
chr13	77570027	77570272	3	3	1	    0.245	0.038	CLN5	0.00827				608102_[CLN5_Ceroid_lipofuscinosis,neuronal,5,256731]
chr13	100764237	100807356	1	3	2	   43.119	0.013	PCCA	0.00119				232000_[PCCA_Propionicacidemia,606054]
chr13	100959436	100959524	1	4	1	    0.088	0.013	PCCA	0.00202				232000_[PCCA_Propionicacidemia,606054]
chr13	103520453	103520617	1	3	1	    0.164	0.134	BIVM-ERCC5,ERCC5	0.01403				133530_[ERCC5_Xeroderma_pigmentosum,group_G,278780/Xeroderma_pigmentosum,group_G/Cockayne_syndrome,278780/Cerebrooculofacioskeletal_syndrome_3,616570]
chr13	110829222	110831393	1	3	2	    2.171	0.159	COL4A1	0.02614				120130_[COL4A1_Porencephaly_1,175780/Brain_small_vessel_disease_with_or_without_ocular_anomalies,607595/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773/Hemorrhage,intracerebral,susceptibility_to,614519/Retinal_arteries,tortuosity_of,180000/Schizencephaly,269160]
chr13	110864754	110864836	1	3	1	    0.082	0.064	COL4A1	0.00985				120130_[COL4A1_Porencephaly_1,175780/Brain_small_vessel_disease_with_or_without_ocular_anomalies,607595/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773/Hemorrhage,intracerebral,susceptibility_to,614519/Retinal_arteries,tortuosity_of,180000/Schizencephaly,269160]
chr13	111117742	111132747	1	6	4	   15.005	0.121	COL4A2	0.04607				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111142048	111142142	1	3	1	    0.094	0.153	COL4A2	0.00713				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111156485	111156621	3	5	1	    0.136	0.089	COL4A2,COL4A2-AS1	0.00215				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr14	23881937	23882090	1	4	1	    0.153	0.108	MYH7	0.00623				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	23887409	23888514	1	3	2	    1.105	0.070	MYH7	0.02430				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	23894481	23894637	1	4	1	    0.156	0.102	MYH7	0.00997				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	23896784	23897889	3	5	2	    1.105	0.096	MYH7	0.01323				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	32047112	32047241	3	4	1	    0.129	0.083	NUBPL	0.00964				613621_[NUBPL_Mitochondrial_complex_I_deficiency,nuclear_type_21,618242]
chr14	32315667	32319417	1	3	2	    3.750	0.108	NUBPL	0.01321				613621_[NUBPL_Mitochondrial_complex_I_deficiency,nuclear_type_21,618242]
chr14	50760823	50760974	1	6	1	    0.151	0.115	L2HGDH	0.00156				609584_[L2HGDH_L-2-hydroxyglutaric_aciduria,236792]
chr14	54421129	54421280	1	4	1	    0.151	0.064	BMP4	0.00610			BMP4	112262_[BMP4_Microphthalmia,syndromic_6,607932/Orofacial_cleft_11,600625]
chr14	64489459	64489591	1	3	1	    0.132	0.038	SYNE2	0.00423				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999]
chr14	64593306	64595281	1	4	2	    1.975	0.083	ESR2,SYNE2	0.00296				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999],601663_[ESR2_Ovarian_dysgenesis_8,618187]
chr14	64644066	64644211	1	4	1	    0.145	0.096	ESR2,SYNE2	0.00528				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999],601663_[ESR2_Ovarian_dysgenesis_8,618187]
chr14	64681994	64683115	3	3	2	    1.121	0.064	ESR2,SYNE2	0.03665				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999],601663_[ESR2_Ovarian_dysgenesis_8,618187]
chr14	68264379	68265349	1	3	2	    0.970	0.070	ZFYVE26	0.04808				612012_[ZFYVE26_Spastic_paraplegia_15,autosomal_recessive,270700]
chr14	77744727	77744861	1	5	1	    0.134	0.070	POMT2	0.00275				607439_[POMT2_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158]
chr14	78021633	78028842	1	6	3	    7.209	0.102	SPTLC2	0.02317				605713_[SPTLC2_Neuropathy,hereditary_sensory_and_autonomic,type_IC,613640]
chr14	81554288	81563061	3	6	4	    8.773	0.070	TSHR	0.04187				603372_[TSHR_Hypothyroidism,congenital,nongoitrous,1_275200/Thyroid_adenoma,hyperfunctioning,somatic/Hyperthyroidism,nonautoimmune,609152/Thyroid_carcinoma_with_thyrotoxicosis/Hyperthyroidism,familial_gestational,603373]
chr14	89076046	89076157	3	3	1	    0.111	0.083	ZC3H14	0.00636				613279_[ZC3H14_Mental_retardation,autosomal_recessive_56,617125]
chr14	92335745	92344036	1	4	2	    8.291	0.045	FBLN5	0.00999				604580_[FBLN5_Cutis_laxa,autosomal_recessive,type_IA,219100/Cutis_laxa,autosomal_dominant_2,614434/Macular_degeneration,age-related,3,608895/Neuropathy,hereditary,with_or_without_age-related_macular_degeneration,608895]
chr14	93684863	93685091	3	5	1	    0.228	0.096	UBR7	0.00185				
chr14	97342357	97342467	3	6	1	    0.110	0.032	VRK1	0.00047				602168_[VRK1_Pontocerebellar_hypoplasia_type_1A,607596]
chr15	32455417	32455546	0	7	1	    0.129	0.599	CHRNA7	0.13959	yes	yes	CHRNA7	
chr15	42679941	42680094	3	4	1	    0.153	0.083	CAPN3	0.00625				114240_[CAPN3_Muscular_dystrophy,limb-girdle,autosomal_recessive_1,253600/Muscular_dystrophy,limb-girdle,autosomal_dominant_4,618129]
chr15	42686444	42686549	3	4	1	    0.105	0.076	CAPN3	0.00189				114240_[CAPN3_Muscular_dystrophy,limb-girdle,autosomal_recessive_1,253600/Muscular_dystrophy,limb-girdle,autosomal_dominant_4,618129]
chr15	42696967	42697163	3	7	1	    0.196	0.127	CAPN3	0.00025				114240_[CAPN3_Muscular_dystrophy,limb-girdle,autosomal_recessive_1,253600/Muscular_dystrophy,limb-girdle,autosomal_dominant_4,618129]
chr15	43268905	43270155	3	5	2	    1.250	0.057	UBR1	0.00341			UBR1	605981_[UBR1_Johanson-Blizzard_syndrome,243800]
chr15	43307876	43308077	1	4	1	    0.201	0.064	UBR1	0.00158			UBR1	605981_[UBR1_Johanson-Blizzard_syndrome,243800]
chr15	44858042	44858217	1	3	1	    0.175	0.102	SPG11	0.00712				610844_[SPG11_Spastic_paraplegia_11,autosomal_recessive,604360/Amyotrophic_lateral_sclerosis_5,juvenile,602099/Charcot-Marie-Tooth_disease,axonal,type_2X,616668]
chr15	44905618	44905744	3	3	1	    0.126	0.102	SPG11	0.00409				610844_[SPG11_Spastic_paraplegia_11,autosomal_recessive,604360/Amyotrophic_lateral_sclerosis_5,juvenile,602099/Charcot-Marie-Tooth_disease,axonal,type_2X,616668]
chr15	44952620	44952824	3	3	1	    0.204	0.064	SPG11	0.00291				610844_[SPG11_Spastic_paraplegia_11,autosomal_recessive,604360/Amyotrophic_lateral_sclerosis_5,juvenile,602099/Charcot-Marie-Tooth_disease,axonal,type_2X,616668]
chr15	45391850	45392100	3	4	1	    0.250	0.070	DUOX2	0.00295				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	45392238	45393046	1	3	2	    0.808	0.127	DUOX2	0.04328				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	45400235	45401160	1	4	2	    0.925	0.064	DUOX2	0.01514				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	49074326	49074437	1	5	1	    0.111	0.038	CEP152	0.00106				613529_[CEP152_Microcephaly_9,primary,autosomal_recessive,614852/Seckel_syndrome_5,613823]
chr15	51217285	51221375	3	4	2	    4.090	0.013	AP4E1	0.00047				607244_[AP4E1_Spastic_paraplegia_51,autosomal_recessive,613744/Stuttering,familial_persistent,1,184450]
chr15	72648856	72668530	3	3	2	   19.674	0.057	HEXA,HEXA-AS1	0.01354				606869_[HEXA_Tay-Sachs_disease,272800/GM2-gangliosidosis,several_forms,272800/Hex_A_pseudodeficiency,272800]
chr15	74490083	74494633	1	5	2	    4.550	0.204	STRA6	0.06351				610745_[STRA6_Microphthalmia,syndromic_9,601186/Microphthalmia,isolated,with_coloboma_8,601186]
chr15	74630093	74631119	3	3	2	    1.026	0.083	CYP11A1	0.02512				118485_[CYP11A1_Adrenal_insufficiency,congenital,with_46XY_sex_reversal,partial_or_complete,613743]
chr15	74631568	74631666	1	4	1	    0.098	0.089	CYP11A1	0.00341				118485_[CYP11A1_Adrenal_insufficiency,congenital,with_46XY_sex_reversal,partial_or_complete,613743]
chr15	75184992	75185153	1	3	1	    0.161	0.127	MPI	0.00835				154550_[MPI_Congenital_disorder_of_glycosylation,type_Ib,602579]
chr15	76523664	76523749	1	3	1	    0.085	0.025	ETFA	0.00235				608053_[ETFA_Glutaric_acidemia_IIA,231680]
chr15	77154176	77154884	1	3	2	    0.708	0.236	SCAPER	0.19274				611611_[SCAPER_Intellectual_developmental_disorder_and_retinitis_pigmentosa,618195]
chr15	89787184	89802017	3	10	3	   14.833	0.051	FANCI	0.00019				611360_[FANCI_Fanconi_anemia,complementation_group_I,609053]
chr15	89807743	89811766	3	3	2	    4.023	0.057	FANCI	0.00480				611360_[FANCI_Fanconi_anemia,complementation_group_I,609053]
chr15	89868671	89868927	3	5	1	    0.256	0.096	POLG	0.00095				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	89876317	89877154	3	4	1	    0.837	0.083	POLG	0.00268				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	90174716	90188406	1	7	5	   13.690	0.089	KIF7	0.00463				611254_[KIF7_Hydrolethalus_syndrome_2,614120/Acrocallosal_syndrome,200990/Joubert_syndrome_12,200990/Al-Gazali-Bakalinova_syndrome,607131]
chr15	91290609	91295186	3	5	3	    4.577	0.038	BLM	0.00875				604610_[BLM_Bloom_syndrome,210900]
chr15	91312658	91328321	1	3	2	   15.663	0.191	BLM	0.04983				604610_[BLM_Bloom_syndrome,210900]
chr16	227272	1254468	3	16	9	 1027.196	0.108	HBA1,CACNA1H	0.01116	yes	yes	HBA1,SSTR5,CACNA1H	141800_[HBA1_Thalassemias,alpha-,604131/Erythrocytosis,7,617981/Hemoglobin_H_disease,nondeletional,613978/Methemoglobinemia,alpha_type,617973/Heinz_body_anemias,alpha-,140700],603816_[AXIN1_Hepatocellular_carcinoma,somatic,114550/Caudal_duplication_anomaly,607864],607207_[STUB1_Spinocerebellar_ataxia,autosomal_recessive_16,615768/Spinocerebellar_ataxia_48,618093],614666_[CCDC78_Centronuclear_myopathy_4,614807],611761_[LMF1_Lipase_deficiency,combined,246650],182455_[SSTR5_Somatostatin_analog,resistance_to],607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1260777	1263941	3	4	6	    3.164	0.242	CACNA1H	0.08904			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1268200	1268661	4	5	1	    0.461	0.172	CACNA1H	0.00289			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1505125	1505806	3	3	2	    0.681	0.217	CLCN7	0.06252				602727_[CLCN7_Osteopetrosis,autosomal_recessive_4,611490/Osteopetrosis,autosomal_dominant_2,166600]
chr16	2105393	2106780	3	6	2	    1.387	0.146	TSC2	0.01945			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2112488	2112611	1	4	1	    0.123	0.096	TSC2	0.00504			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2131586	2131809	1	4	1	    0.223	0.102	TSC2	0.00446			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2132427	2133827	3	5	2	    1.400	0.127	TSC2	0.01027			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2137854	2138150	3	3	2	    0.296	0.223	TSC2	0.04034			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2155313	2155485	4	4	1	    0.172	0.159	PKD1	0.00252	yes		PKD1	601313_[PKD1_Polycystic_kidney_disease_1,173900]
chr16	2353960	2354161	3	5	1	    0.201	0.140	ABCA3	0.00235				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	2369572	2369851	3	3	1	    0.279	0.146	ABCA3	0.00341				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	3297006	3299014	3	7	2	    2.008	0.045	MEFV	0.00608				608107_[MEFV_Familial_Mediterranean_fever,AR,249100/Familial_Mediterranean_fever,AD,134610]
chr16	3781767	3786214	3	4	2	    4.447	0.255	CREBBP	0.03258			CREBBP	600140_[CREBBP_Rubinstein-Taybi_syndrome_1,180849]
chr16	3830723	3830889	3	5	1	    0.166	0.096	CREBBP	0.00144			CREBBP	600140_[CREBBP_Rubinstein-Taybi_syndrome_1,180849]
chr16	5127436	5127545	3	5	1	    0.109	0.185	ALG1	0.00233				605907_[ALG1_Congenital_disorder_of_glycosylation,type_Ik,608540]
chr16	5132550	5132684	3	7	1	    0.134	0.070	ALG1	0.00017				605907_[ALG1_Congenital_disorder_of_glycosylation,type_Ik,608540]
chr16	10031806	10276273	3	4	3	  244.467	0.076	GRIN2A	0.01403			GRIN2A	138253_[GRIN2A_Epilepsy,focal,with_speech_disorder_and_with_or_without_mental_retardation,245570]
chr16	11002876	11003054	3	3	1	    0.178	0.115	CIITA	0.00314				600005_[CIITA_Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920/Rheumatoid_arthritis,susceptibility_to,180300]
chr16	11016254	11016357	1	3	1	    0.103	0.070	CIITA	0.00350				600005_[CIITA_Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920/Rheumatoid_arthritis,susceptibility_to,180300]
chr16	23430011	23436278	1	4	2	    6.267	0.096	COG7	0.02118				606978_[COG7_Congenital_disorder_of_glycosylation,type_IIe,608779]
chr16	28500601	28500717	3	4	1	    0.116	0.076	CLN3	0.00276				607042_[CLN3_Ceroid_lipofuscinosis,neuronal,3,204200]
chr16	30081428	30195674	3	6	3	  114.246	0.083	ALDOA,CORO1A	0.05321	yes		ALDOA,TBX6	103850_[ALDOA_Glycogen_storage_disease_XII,611881],602427_[TBX6_Spondylocostal_dysostosis_5,122600],605000_[CORO1A_Immunodeficiency_8,615401]
chr16	31195169	31195333	1	4	1	    0.164	0.096	FUS	0.00370				137070_[FUS_Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030/Essential_tremor,hereditary,4,614782]
chr16	31196250	31200557	3	4	2	    4.307	0.121	FUS	0.00076				137070_[FUS_Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030/Essential_tremor,hereditary,4,614782]
chr16	53690374	53690511	3	3	1	    0.137	0.108	RPGRIP1L	0.00959				610937_[RPGRIP1L_Joubert_syndrome_7,611560/Meckel_syndrome_5,611561/COACH_syndrome,216360]
chr16	53691355	53706938	1	9	3	   15.583	0.096	RPGRIP1L	0.00291				610937_[RPGRIP1L_Joubert_syndrome_7,611560/Meckel_syndrome_5,611561/COACH_syndrome,216360]
chr16	56553648	57485130	3	6	2	  931.482	0.108	BBS2,COQ9	0.00047	yes	yes	SLC12A3	606151_[BBS2_Bardet-Biedl_syndrome_2,615981/Retinitis_pigmentosa_74,616562],614351_[NUP93_Nephrotic_syndrome,type_12,616892],600968_[SLC12A3_Gitelman_syndrome,263800],118470_[CETP_Hyperalphalipoproteinemia,143470/High_density_lipoprotein_cholesterol_level_QTL_10,143470],616585_[RSPRY1_Spondyloepimetaphyseal_dysplasia,Faden-Alkuraya_type,616723],615407_[ARL2BP_Retinitis_pigmentosa_with_or_without_situs_inversus,615434],612837_[COQ9_Coenzyme_Q10_deficiency,primary,5,614654]
chr16	66503495	66511623	3	3	2	    8.128	0.102	BEAN1	0.01059				612051_[BEAN1_Spinocerebellar_ataxia_31,117210]
chr16	67470142	67470299	1	3	1	    0.157	0.140	HSD11B2	0.00499				614232_[HSD11B2_Apparent_mineralocorticoid_excess,218030]
chr16	70296239	70299015	3	5	2	    2.776	0.038	AARS	0.00132				601065_[AARS_Charcot-Marie-Tooth_disease,axonal,type_2N,613287/Epileptic_encephalopathy,early_infantile,29,616339]
chr16	70310859	70311067	3	4	1	    0.208	0.089	AARS	0.00942				601065_[AARS_Charcot-Marie-Tooth_disease,axonal,type_2N,613287/Epileptic_encephalopathy,early_infantile,29,616339]
chr16	71609815	71609939	1	6	1	    0.124	0.096	TAT	0.00159				613018_[TAT_Tyrosinemia,type_II,276600]
chr16	81396094	81397558	3	7	2	    1.464	0.134	GAN	0.00412				605379_[GAN_Giant_axonal_neuropathy-1,256850]
chr16	89597081	89598484	3	4	2	    1.403	0.115	SPG7	0.00875				602783_[SPG7_Spastic_paraplegia_7,autosomal_recessive,607259]
chr17	1264376	2541624	1	4	5	 1277.248	0.057	YWHAE,PAFAH1B1	0.07556	yes	yes	YWHAE,PAFAH1B1	607875_[INPP5K_Muscular_dystrophy,congenital,with_cataracts_and_intellectual_disability,617404],607300_[PRPF8_Retinitis_pigmentosa_13,600059],614218_[WDR81_Cerebellar_ataxia,mental_retardation,and_dysequilibrium_syndrome_2,610185/Hydrocephalus,congenital,3,with_brain_anomalies,617967],613168_[SERPINF2_Alpha-2-plasmin_inhibitor_deficiency,262850],172860_[SERPINF1_Osteogenesis_imperfecta,type_VI,613982],603527_[DPH1_Developmental_delay_with_short_stature,dysmorphic_features,and_sparse_hair,616901],247200_[PAFAH1B1_Miller-Dieker_lissencephaly_syndrome],601545_[PAFAH1B1_Lissencephaly_1,607432/Subcortical_laminar_heterotopia,607432]
chr17	2570276	2570502	3	4	1	    0.226	0.134	PAFAH1B1	0.00423			PAFAH1B1	247200_[PAFAH1B1_Miller-Dieker_lissencephaly_syndrome],601545_[PAFAH1B1_Lissencephaly_1,607432/Subcortical_laminar_heterotopia,607432]
chr17	3397634	3397763	3	3	1	    0.129	0.102	ASPA,SPATA22	0.00875			ASPA	608034_[ASPA_Canavan_disease,271900]
chr17	7351888	7357849	3	13	2	    5.961	0.096	CHRNB1	0.00001				100710_[CHRNB1_Myasthenic_syndrome,congenital,2A,slow-channel,616313/Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314]
chr17	10307637	10307912	3	4	1	    0.275	0.089	MYH8	0.00168				160741_[MYH8_Carney_complex_variant,608837/Trismus-pseudocamptodactyly_syndrome,158300]
chr17	10542351	10542801	1	3	2	    0.450	0.064	MYH3	0.00976				160720_[MYH3_Arthrogryposis,distal,type_2A,193700/Arthrogryposis,distal,type_2B,601680/Arthrogryposis,distal,type_8,178110]
chr17	10596071	10596288	3	3	1	    0.217	0.051	SCO1	0.00247				603644_[SCO1_Mitochondrial_complex_IV_deficiency,220110]
chr17	15163957	15165899	3	7	2	    1.942	0.140	PMP22	0.00072			PMP22	601097_[PMP22_Charcot-Marie-Tooth_disease,type_1A,118220/Dejerine-Sottas_disease,145900/Neuropathy,recurrent,with_pressure_palsies,162500/Charcot-Marie-Tooth_disease,type_1E,118300/Roussy-Levy_syndrome,180800/Neuropathy,inflammatory_demyelinating,139393]
chr17	15928321	15928495	1	4	1	    0.174	0.096	TTC19	0.00477				613814_[TTC19_Mitochondrial_complex_III_deficiency,nuclear_type_2,615157]
chr17	17627332	17701837	3	6	2	   74.505	0.096	RAI1	0.00673			RAI1	607642_[RAI1_Smith-Magenis_syndrome,182290]
chr17	29528045	29528513	1	3	2	    0.468	0.121	NF1	0.04106			NF1	613113_[NF1_Neurofibromatosis,type_1,162200/Leukemia,juvenile_myelomonocytic,607785/Neurofibromatosis,familial_spinal,162210/Neurofibromatosis-Noonan_syndrome,601321/Watson_syndrome,193520]
chr17	29557850	29557953	3	4	1	    0.103	0.127	NF1	0.00215	yes		NF1	613113_[NF1_Neurofibromatosis,type_1,162200/Leukemia,juvenile_myelomonocytic,607785/Neurofibromatosis,familial_spinal,162210/Neurofibromatosis-Noonan_syndrome,601321/Watson_syndrome,193520]
chr17	40368022	40368134	3	4	1	    0.112	0.083	STAT5B	0.00315				604260_[STAT5B_Leukemia,acute_promyelocytic,somatic,102578/Growth_hormone_insensitivity_with_immunodeficiency,245590]
chr17	42151518	42152148	1	3	2	    0.630	0.083	G6PC3	0.01095				611045_[G6PC3_Neutropenia,severe_congenital_4,autosomal_recessive,612541/Dursun_syndrome,612541]
chr17	44847139	44847424	3	5	1	    0.285	0.089	WNT3	0.00164				165330_[WNT3_Tetra-amelia_syndrome_1,273395]
chr17	45361799	45362071	1	4	1	    0.272	0.115	ITGB3	0.00613				173470_[ITGB3_Glanzmann_thrombasthenia,273800/Thrombocytopenia,neonatal_alloimmune/Myocardial_infarction,susceptibility_to,608446/Purpura,posttransfusion/Bleeding_disorder,platelet-type,16,autosomal_dominant,187800]
chr17	45384827	45385013	3	7	1	    0.186	0.076	ITGB3	0.00023				173470_[ITGB3_Glanzmann_thrombasthenia,273800/Thrombocytopenia,neonatal_alloimmune/Myocardial_infarction,susceptibility_to,608446/Purpura,posttransfusion/Bleeding_disorder,platelet-type,16,autosomal_dominant,187800]
chr17	48263668	48271818	3	25	14	    8.150	0.096	COL1A1	0.00054			COL1A1	120150_[COL1A1_Osteogenesis_imperfecta,type_I,166200/Osteogenesis_imperfecta,type_II,166210/Osteogenesis_imperfecta,type_III,259420/Caffey_disease,114000/Osteogenesis_imperfecta,type_IV,166220/Bone_mineral_density_variation_QTL,osteoporosis,166710/Ehlers-Danlos_syndrome,arthrochalasia_type,1,130060]
chr17	48272583	48272701	3	3	1	    0.118	0.121	COL1A1	0.01119			COL1A1	120150_[COL1A1_Osteogenesis_imperfecta,type_I,166200/Osteogenesis_imperfecta,type_II,166210/Osteogenesis_imperfecta,type_III,259420/Caffey_disease,114000/Osteogenesis_imperfecta,type_IV,166220/Bone_mineral_density_variation_QTL,osteoporosis,166710/Ehlers-Danlos_syndrome,arthrochalasia_type,1,130060]
chr17	48649229	48649408	3	4	1	    0.179	0.153	CACNA1G	0.00335				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48673913	48677230	3	4	2	    3.317	0.178	CACNA1G	0.02917				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48681506	48685411	3	4	4	    3.905	0.121	CACNA1G	0.01500				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48696006	48696379	3	8	1	    0.373	0.076	CACNA1G	0.00017				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	56284436	56284589	1	4	1	    0.153	0.045	MKS1	0.00659				609883_[MKS1_Meckel_syndrome_1,249000/Bardet-Biedl_syndrome_13,615990/Joubert_syndrome_28,617121]
chr17	59870948	59876670	3	9	2	    5.722	0.064	BRIP1	0.00100				605882_[BRIP1_Breast_cancer,early-onset,114480/Fanconi_anemia,complementation_group_J,609054]
chr17	61994553	61994876	3	4	1	    0.323	0.096	CSHL1,GH1	0.00164			GH1	139250_[GH1_Growth_hormone_deficiency,isolated,type_IA,262400/Growth_hormone_deficiency,isolated,type_IB,612781/Growth_hormone_deficiency,isolated,type_II,173100/Kowarski_syndrome,262650]
chr17	61995696	62006694	1	5	3	   10.998	0.057	CSHL1,GH1,CD79B	0.00794			GH1	139250_[GH1_Growth_hormone_deficiency,isolated,type_IA,262400/Growth_hormone_deficiency,isolated,type_IB,612781/Growth_hormone_deficiency,isolated,type_II,173100/Kowarski_syndrome,262650],147245_[CD79B_Agammaglobulinemia_6,612692]
chr17	62015904	62024537	3	6	6	    8.633	0.102	SCN4A	0.02166				603967_[SCN4A_Hyperkalemic_periodic_paralysis,type_2,170500/Paramyotonia_congenita,168300/Myotonia_congenita,atypical,acetazolamide-responsive,608390/Myasthenic_syndrome,congenital,16,614198/Hypokalemic_periodic_paralysis,type_2,613345]
chr17	62034512	62036808	3	8	2	    2.296	0.134	SCN4A	0.00158				603967_[SCN4A_Hyperkalemic_periodic_paralysis,type_2,170500/Paramyotonia_congenita,168300/Myotonia_congenita,atypical,acetazolamide-responsive,608390/Myasthenic_syndrome,congenital,16,614198/Hypokalemic_periodic_paralysis,type_2,613345]
chr17	62489002	62489148	3	6	1	    0.146	0.076	POLG2	0.00130				604983_[POLG2_Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_dominant_4,610131]
chr17	72915539	72916776	3	3	1	    1.237	0.108	USH1G	0.02008				607696_[USH1G_Usher_syndrome,type_1G,606943]
chr17	73750647	73750906	3	4	1	    0.259	0.115	GALK1,ITGB4	0.00326				147557_[ITGB4_Epidermolysis_bullosa,junctional,with_pyloric_atresia,226730/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa_of_hands_and_feet,131800],604313_[GALK1_Galactokinase_deficiency_with_cataracts,230200]
chr17	73826649	73826752	1	4	1	    0.103	0.115	UNC13D	0.00241				608897_[UNC13D_Hemophagocytic_lymphohistiocytosis,familial,3,608898]
chr17	73835910	73836201	3	2	2	    0.291	0.140	UNC13D	0.05477				608897_[UNC13D_Hemophagocytic_lymphohistiocytosis,familial,3,608898]
chr17	75483496	75486951	3	5	4	    3.455	0.096	SEPT9	0.02541	yes			604061_[SEPT9_Leukemia,acute_myeloid,therapy-related/Ovarian_carcinoma/Amyotrophy,hereditary_neuralgic,162100]
chr17	76113873	76115137	3	5	2	    1.264	0.083	TMC6	0.00516				605828_[TMC6_Epidermodysplasia_verruciformis,226400]
chr17	76129477	76129633	1	4	1	    0.156	0.089	TMC8	0.00335				605829_[TMC8_Epidermodysplasia_verruciformis_2,618231]
chr17	78183069	78186083	3	5	2	    3.014	0.032	CARD14,SGSH	0.00280				607211_[CARD14_Psoriasis_2,602723/Pityriasis_rubra_pilaris,173200],605270_[SGSH_Mucopolysaccharidosis_type_IIIA_(Sanfilippo_A),252900]
chr17	79478919	79479396	3	4	2	    0.477	0.210	ACTG1	0.00835				102560_[ACTG1_Deafness,autosomal_dominant_20/26,604717/Baraitser-Winter_syndrome_2,614583]
chr17	79893203	79893402	1	4	1	    0.199	0.045	PYCR1	0.00290				179035_[PYCR1_Cutis_laxa,autosomal_recessive,type_IIB,612940/Cutis_laxa,autosomal_recessive,type_IIIB,614438]
chr17	79894614	80038124	3	14	4	  143.510	0.121	PYCR1,FASN	0.00005	yes			179035_[PYCR1_Cutis_laxa,autosomal_recessive,type_IIB,612940/Cutis_laxa,autosomal_recessive,type_IIIB,614438],600864_[ASPSCR1_Advanced_sleep-phase_syndrome,familial,2,615224],606236_[ASPSCR1_Alveolar_soft-part_sarcoma,606243],608347_[DCXR_Pentosuria,260800]
chr17	80040189	80040564	1	4	2	    0.375	0.064	FASN	0.00241				
chr17	80583255	80588908	3	3	3	    5.653	0.146	WDR45B	0.08750				609226_[WDR45B_Neurodevelopmental_disorder_with_spastic_quadriplegia_and_brain_abnormalities_with_or_without_seizures,617977]
chr18	3450162	3450513	3	4	1	    0.351	0.108	TGIF1	0.00572			TGIF1	602630_[TGIF1_Holoprosencephaly_4,142946]
chr18	7023153	7024475	1	3	2	    1.322	0.166	LAMA1	0.10606				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	7080276	9117911	1	6	2	 2037.635	0.083	LAMA1,NDUFV2	0.01115	yes	yes		150320_[LAMA1_Poretti-Boltshauser_syndrome,615960],600532_[NDUFV2_Mitochondrial_complex_I_deficiency,nuclear_type_7,618229]
chr18	12363771	12363865	1	3	1	    0.094	0.038	AFG3L2	0.00805				604581_[AFG3L2_Spinocerebellar_ataxia_28,610246/Spastic_ataxia_5,autosomal_recessive,614487]
chr18	21134712	21136587	3	9	2	    1.875	0.083	NPC1	0.00022				607623_[NPC1_Niemann-Pick_disease,type_C1,257220/Niemann-Pick_disease,type_D,257220]
chr18	21406656	21407441	1	5	2	    0.785	0.108	LAMA3	0.01828				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21479242	21484668	1	7	5	    5.426	0.089	LAMA3	0.04103				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21508579	21508739	3	5	1	    0.160	0.070	LAMA3	0.00116				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	33713191	33713289	3	4	1	    0.098	0.057	ELP2	0.00665				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	33739688	33739803	1	3	1	    0.115	0.064	ELP2	0.00405				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	42456520	42457389	1	4	1	    0.869	0.096	SETBP1	0.00491			SETBP1	611060_[SETBP1_Schinzel-Giedion_midface_retraction_syndrome,269150/Mental_retardation,autosomal_dominant_29,616078]
chr18	42618440	42618630	3	4	1	    0.190	0.102	SETBP1	0.00303			SETBP1	611060_[SETBP1_Schinzel-Giedion_midface_retraction_syndrome,269150/Mental_retardation,autosomal_dominant_29,616078]
chr18	52899730	52901924	3	4	2	    2.194	0.070	TCF4	0.00606			TCF4	602272_[TCF4_Pitt-Hopkins_syndrome,610954/Corneal_dystrophy,Fuchs_endothelial,3,613267]
chr18	53298519	53298629	3	5	1	    0.110	0.134	TCF4	0.00124			TCF4	602272_[TCF4_Pitt-Hopkins_syndrome,610954/Corneal_dystrophy,Fuchs_endothelial,3,613267]
chr18	55371777	55373829	3	3	2	    2.052	0.096	ATP8B1	0.02008				602397_[ATP8B1_Cholestasis,progressive_familial_intrahepatic_1,211600/Cholestasis,benign_recurrent_intrahepatic,243300/Cholestasis,intrahepatic,of_pregnancy,1,147480]
chr19	863082	863620	3	6	1	    0.538	0.134	CFD	0.00069				134350_[CFD_Complement_factor_D_deficiency,613912]
chr19	3653278	3656565	3	4	2	    3.287	0.102	PIP5K1C	0.02508				606102_[PIP5K1C_Lethal_congenital_contractural_syndrome_3,611369]
chr19	4090310	4095457	3	4	2	    5.147	0.204	MAP2K2	0.01935			MAP2K2	601263_[MAP2K2_Cardiofaciocutaneous_syndrome_4,615280]
chr19	6707077	6707294	4	4	1	    0.217	0.153	C3	0.00635			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	6710988	6712427	3	7	2	    1.439	0.045	C3	0.00214			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	6719212	6719424	4	5	1	    0.212	0.191	C3	0.00304			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	7170538	7172455	3	6	2	    1.917	0.038	INSR	0.00152				147670_[INSR_Leprechaunism,246200/Rabson-Mendenhall_syndrome,262190/Diabetes_mellitus,insulin-resistant,with_acanthosis_nigricans,610549/Hyperinsulinemic_hypoglycemia,familial,5,609968]
chr19	7593473	7595397	3	4	5	    1.924	0.127	MCOLN1	0.13155				605248_[MCOLN1_Mucolipidosis_IV,252650]
chr19	7707305	7709648	3	8	4	    2.343	0.185	STXBP2	0.06864				601717_[STXBP2_Hemophagocytic_lymphohistiocytosis,familial,5,613101]
chr19	10244012	10247966	3	11	4	    3.954	0.057	DNMT1	0.00164				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10248498	10248695	1	3	1	    0.197	0.115	DNMT1	0.00613				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10286206	10286304	3	4	1	    0.098	0.032	DNMT1	0.00234				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10467234	10467404	3	4	1	    0.170	0.102	TYK2	0.00215				176941_[TYK2_Immunodeficiency_35,611521]
chr19	10909152	10930775	3	4	4	   21.623	0.166	DNM2	0.08728				602378_[DNM2_Charcot-Marie-Tooth_disease,dominant_intermediate_B,606482/Centronuclear_myopathy_1,160150/Charcot-Marie-Tooth_disease,axonal_type_2M,606482/Lethal_congenital_contracture_syndrome_5,615368]
chr19	11091443	11097689	3	3	3	    6.246	0.070	SMARCA4	0.00720			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11123615	11123798	4	5	1	    0.183	0.223	SMARCA4	0.00224			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11136088	11138636	3	3	2	    2.548	0.248	SMARCA4	0.01284			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11143956	11144203	4	6	1	    0.247	0.159	SMARCA4	0.00004			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11144433	11144551	1	3	1	    0.118	0.096	SMARCA4	0.00980			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11169454	11170571	3	5	2	    1.117	0.197	SMARCA4	0.00155			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	12769232	12774286	3	9	3	    5.054	0.038	MAN2B1	0.00552				609458_[MAN2B1_Mannosidosis,alpha-,types_I_and_II,248500]
chr19	13218378	13220508	3	3	4	    2.130	0.089	TRMT1	0.06414				
chr19	13372254	13372434	3	3	1	    0.180	0.096	CACNA1A	0.01059			CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106]
chr19	13414571	13419075	3	4	3	    4.504	0.134	CACNA1A	0.03414			CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106]
chr19	13616736	14023261	3	7	3	  406.525	0.121	CACNA1A,CC2D1A	0.00576	yes	yes	CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106],610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	14040182	14041703	3	5	4	    1.521	0.108	CC2D1A	0.01385				610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	15296288	15297809	3	3	2	    1.521	0.076	NOTCH3	0.02923			NOTCH3	600276_[NOTCH3_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310/Myofibromatosis,infantile_2,615293/Lateral_meningocele_syndrome,130720]
chr19	17945370	17948032	1	4	5	    2.662	0.102	JAK3	0.00144				600173_[JAK3_SCID,autosomal_recessive,T-negative/B-positive_type,600802]
chr19	18170694	18170905	1	3	1	    0.211	0.064	IL12RB1	0.00613				601604_[IL12RB1_Immunodeficiency_30,614891]
chr19	34859478	34859617	3	5	1	    0.139	0.102	GPI	0.00185				172400_[GPI_Hemolytic_anemia,nonspherocytic,due_to_glucose_phosphate_isomerase_deficiency,613470]
chr19	34869829	34884223	3	5	2	   14.394	0.070	GPI	0.01531				172400_[GPI_Hemolytic_anemia,nonspherocytic,due_to_glucose_phosphate_isomerase_deficiency,613470]
chr19	36333271	36333462	1	4	1	    0.191	0.115	NPHS1	0.00364				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36335211	36336452	1	3	2	    1.241	0.057	NPHS1	0.01063				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36342154	36342296	1	3	1	    0.142	0.064	NPHS1	0.00222				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36584923	36590529	3	5	2	    5.606	0.083	WDR62	0.00055				613583_[WDR62_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317]
chr19	36595410	38931514	1	4	4	 2336.104	0.115	WDR62,RYR1	0.01806	yes	yes		613583_[WDR62_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317],616655_[SIPA1L3_Cataract_45,616851],605124_[SPINT2_Diarrhea_3,secretory_sodium,congenital,syndromic,270420],180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38932979	38934446	3	7	3	    1.467	0.127	RYR1	0.00034				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38959596	38959790	3	3	1	    0.194	0.051	RYR1	0.00329				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38976220	38980093	3	5	2	    3.873	0.140	RYR1	0.00651				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39006717	39006867	1	3	1	    0.150	0.089	RYR1	0.00548				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39028510	39034525	3	5	4	    6.015	0.127	RYR1	0.06841				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	40913803	40913948	1	4	1	    0.145	0.115	PRX	0.00311				605725_[PRX_Dejerine-Sottas_disease,145900/Charcot-Marie-Tooth_disease,type_4F,614895]
chr19	41928893	41929084	3	3	1	    0.191	0.025	BCKDHA	0.00983				608348_[BCKDHA_Maple_syrup_urine_disease,type_Ia,248600]
chr19	45855457	45855620	1	5	1	    0.163	0.076	ERCC2	0.00208				126340_[ERCC2_Xeroderma_pigmentosum,group_D,278730/Trichothiodystrophy_1,photosensitive,601675/Cerebrooculofacioskeletal_syndrome_2,610756]
chr19	45857978	45864910	3	8	7	    6.932	0.051	ERCC2	0.05855				126340_[ERCC2_Xeroderma_pigmentosum,group_D,278730/Trichothiodystrophy_1,photosensitive,601675/Cerebrooculofacioskeletal_syndrome_2,610756]
chr19	45918109	45918228	3	5	1	    0.119	0.083	ERCC1	0.00130				126380_[ERCC1_Cerebrooculofacioskeletal_syndrome_4,610758]
chr19	46282512	46282790	3	2	2	    0.278	0.096	DMPK	0.02055				605377_[DMPK_Myotonic_dystrophy_1,160900]
chr19	50332217	50333215	3	4	2	    0.998	0.134	MED25	0.01316				610197_[MED25_Charcot-Marie-Tooth_disease,type_2B2,605589/Basel-Vanagait-Smirin-Yosef_syndrome,616449]
chr19	50338233	50365875	3	11	9	   27.642	0.083	MED25,PNKP	0.10606				610197_[MED25_Charcot-Marie-Tooth_disease,type_2B2,605589/Basel-Vanagait-Smirin-Yosef_syndrome,616449],605610_[PNKP_Microcephaly,seizures,and_developmental_delay,613402/Ataxia-oculomotor_apraxia_4,616267]
chr19	50430941	50827349	3	9	5	  396.408	0.051	IL4I1,NUP62,ATF5,KCNC3	0.00372	yes	yes		605815_[NUP62_Striatonigral_degeneration,infantile,271930],608568_[MYH14_Deafness,autosomal_dominant_4A,600652/Peripheral_neuropathy,myopathy,hoarseness,and_hearing_loss,614369],176264_[KCNC3_Spinocerebellar_ataxia_13,605259]
chr19	54694109	54694311	4	6	1	    0.202	0.204	TSEN34	0.00134				608754_[TSEN34_Pontocerebellar_hypoplasia_type_2C,612390]
chr20	3208053	3210432	3	5	7	    2.379	0.102	SLC4A11	0.06996				610206_[SLC4A11_Corneal_endothelial_dystrophy,autosomal_recessive,217700/Corneal_endothelial_dystrophy_and_perceptive_deafness,217400/Corneal_dystrophy,Fuchs_endothelial,4,613268]
chr20	3211569	3211898	3	2	2	    0.329	0.153	SLC4A11	0.07398				610206_[SLC4A11_Corneal_endothelial_dystrophy,autosomal_recessive,217700/Corneal_endothelial_dystrophy_and_perceptive_deafness,217400/Corneal_dystrophy,Fuchs_endothelial,4,613268]
chr20	10628598	10628768	3	4	1	    0.170	0.057	JAG1	0.00290			JAG1	601920_[JAG1_Alagille_syndrome_1,118450/Tetralogy_of_Fallot,187500/Deafness,congenital_heart_defects,and_posterior_embryotoxon,617992]
chr20	30954177	30960362	3	4	3	    6.185	0.051	ASXL1	0.05104			ASXL1	612990_[ASXL1_Bohring-Opitz_syndrome,605039/Myelodysplastic_syndrome,somatic,614286]
chr20	31386256	31386459	1	4	1	    0.203	0.153	DNMT3B	0.00613			DNMT3B	602900_[DNMT3B_Immunodeficiency-centromeric_instability-facial_anomalies_syndrome_1,242860]
chr20	35545115	35545462	1	2	2	    0.347	0.172	SAMHD1	0.05714				606754_[SAMHD1_Aicardi-Goutieres_syndrome_5,612952/Chilblain_lupus_2,614415]
chr20	44751755	44751868	3	3	1	    0.113	0.185	CD40	0.01771				109535_[CD40_Immunodeficiency_with_hyper-IgM,type_3,606843]
chr20	57478717	57478856	3	3	1	    0.139	0.083	GNAS	0.00515			GNAS	139320_[GNAS_Pseudohypoparathyroidism_Ia,103580/McCune-Albright_syndrome,somatic,mosaic_174800/Pseudohypoparathyroidism_Ic,612462/Osseous_heteroplasia,progressive,166350/Pseudohypoparathyroidism_Ib,603233/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudopseudohypoparathyroidism,612463/ACTH-independent_macronodular_adrenal_hyperplasia,219080]
chr20	61980995	61991061	3	6	3	   10.066	0.223	CHRNA4	0.01649	yes		CHRNA4	118504_[CHRNA4_Epilepsy,nocturnal_frontal_lobe,1,600513/Nicotine_addiction,susceptibility_to,188890]
chr20	62070941	62073894	3	7	2	    2.953	0.127	KCNQ2	0.00176			KCNQ2	602235_[KCNQ2_Seizures,benign_neonatal,1,121200/Myokymia,121200/Epileptic_encephalopathy,early_infantile,7,613720]
chr20	62560655	62560888	4	3	1	    0.233	0.261	DNAJC5	0.00604				611203_[DNAJC5_Ceroid_lipofuscinosis,neuronal,4,Parry_type,162350]
chr21	27269875	27284284	3	3	2	   14.409	0.013	APP	0.00832	yes		APP	104760_[APP_Cerebral_amyloid_angiopathy,Dutch,Italian,Iowa,Flemish,Arctic_variants,605714/Alzheimer_disease_1,familial,104300]
chr21	38334326	38782982	3	3	2	  448.656	0.064	HLCS,DYRK1A	0.00536			HLCS,RIPPLY3,PIGP,TTC3,DSCR9,DSCR3,DYRK1A	609018_[HLCS_Holocarboxylase_synthetase_deficiency,253270],605938_[PIGP_Epileptic_encephalopathy,early_infantile,55,617599],600855_[DYRK1A_Mental_retardation,autosomal_dominant_7,614104]
chr21	38852930	38853138	3	5	1	    0.208	0.115	DYRK1A	0.00130			DYRK1A	600855_[DYRK1A_Mental_retardation,autosomal_dominant_7,614104]
chr21	44485303	44485815	1	5	3	    0.512	0.070	CBS	0.00064				613381_[CBS_Homocystinuria,B6-responsive_and_nonresponsive_types,236200/Thrombosis,hyperhomocysteinemic,236200]
chr21	46305858	46308820	3	4	3	    2.962	0.096	ITGB2	0.06129				600065_[ITGB2_Leukocyte_adhesion_deficiency,116920]
chr21	46326820	46327020	3	3	1	    0.200	0.108	ITGB2	0.01306				600065_[ITGB2_Leukocyte_adhesion_deficiency,116920]
chr21	46875414	46888710	3	8	2	   13.296	0.083	COL18A1	0.00419				120328_[COL18A1_Knobloch_syndrome,type_1,267750]
chr21	46901867	46915356	3	6	4	   13.489	0.076	COL18A1	0.00048	yes			120328_[COL18A1_Knobloch_syndrome,type_1,267750]
chr21	47410883	47412734	1	3	3	    1.851	0.064	COL6A1	0.00613			COL6A1	120220_[COL6A1_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090]
chr21	47417325	47418883	1	4	3	    1.558	0.057	COL6A1	0.03336			COL6A1	120220_[COL6A1_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090]
chr21	47551858	47744206	3	5	2	  192.348	0.210	COL6A2,PCNT	0.00997	yes	yes	COL6A2	120240_[COL6A2_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090/Myosclerosis,congenital,255600],606806_[FTCD_Glutamate_formiminotransferase_deficiency,229100],600909_[LSS_Cataract_44,616509/Hypotrichosis_14,618275],603294_[MCM3AP_Peripheral_neuropathy,autosomal_recessive,with_or_without_impaired_intellectual_development,618124],605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47773008	47773992	3	3	2	    0.984	0.159	PCNT	0.04931				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47809104	47809356	3	4	1	    0.252	0.083	PCNT	0.00224				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47849914	47850156	3	5	1	    0.242	0.108	PCNT	0.00224				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47856882	47858260	1	3	2	    1.378	0.064	PCNT	0.00258				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr22	24916345	24919751	1	6	2	    3.406	0.102	UPB1	0.00583				606673_[UPB1_Beta-ureidopropionase_deficiency,613161]
chr22	31010326	31010498	1	3	1	    0.172	0.089	TCN2	0.00544				613441_[TCN2_Transcobalamin_II_deficiency,275350]
chr22	33712061	33712244	3	5	1	    0.183	0.089	LARGE1	0.00177			LARGE1	603590_[LARGE1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,6,613154/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,6,608840]
chr22	37266447	37274069	3	4	4	    7.622	0.051	NCF4,NCF4-AS1	0.00675				601488_[NCF4_Granulomatous_disease,chronic,autosomal_recessive,cytochrome_b-positive,type_III,613960]
chr22	38373864	38374152	3	5	1	    0.288	0.108	POLR2F,SOX10	0.00224			SOX10	602229_[SOX10_Waardenburg_syndrome,type_4C,613266/Waardenburg_syndrome,type_2E,with_or_without_neurologic_involvement,611584/PCWH_syndrome,609136]
chr22	42522843	42524362	1	5	4	    1.519	0.051	CYP2D6,NDUFA6-DT	0.00458	yes	yes	CYP2D6	124030_[CYP2D6_Debrisoquine_sensitivity,608902/Codeine_sensitivity,608902]
chr22	42525025	42526893	1	5	2	    1.868	0.038	CYP2D6,NDUFA6-DT	0.00006	yes	yes	CYP2D6	124030_[CYP2D6_Debrisoquine_sensitivity,608902/Codeine_sensitivity,608902]
chrX	2852663	13764584	2	234	71	10911.921	0.006	ARSE,NLGN4X,CLCN4,MID1,HCCS,ARHGAP6,FRMPD4,OFD1	0.00000	yes	yes	ARSE,NLGN4X,VCX3A,STS,ANOS1,GPR143,MID1,HCCS,TRAPPC2,OFD1	300180_[ARSE_Chondrodysplasia_punctata,X-linked_recessive,302950],300427_[NLGN4X_Autism_susceptibility,X-linked_2,300495/Asperger_syndrome_susceptibility,X-linked_2,300497/Mental_retardation,X-linked,300495],300747_[STS_Ichthyosis,X-linked,308100],300836_[ANOS1_Hypogonadotropic_hypogonadism_1_with_or_without_anosmia_(Kallmann_syndrome_1),308700],300808_[GPR143_Ocular_albinism,type_I,Nettleship-Falls_type,300500/Nystagmus_6,congenital,X-linked,300814],302910_[CLCN4_Raynaud-Claes_syndrome,300114],300552_[MID1_Opitz_GBBB_syndrome,type_I,300000],300056_[HCCS_Linear_skin_defects_with_multiple_congenital_anomalies_1,309801],300391_[AMELX_Amelogenesis_imperfecta,type_1E,301200],300838_[FRMPD4_Mental_retardation,X-linked_104,300983],300202_[TRAPPC2_Spondyloepiphyseal_dysplasia_tarda,313400],300170_[OFD1_Orofaciodigital_syndrome_I,311200/Simpson-Golabi-Behmel_syndrome,type_2,300209/Joubert_syndrome_10,300804/Retinitis_pigmentosa_23,300424]
chrX	13779194	20193416	2	250	71	 6414.222	0.006	OFD1,FANCB,PIGA,AP1S2,NHS,CDKL5,RS1,PDHA1,MAP3K15,RPS6KA3	0.00000	yes	yes	OFD1,FANCB,AP1S2,NHS,CDKL5,RS1,PDHA1,RPS6KA3	300170_[OFD1_Orofaciodigital_syndrome_I,311200/Simpson-Golabi-Behmel_syndrome,type_2,300209/Joubert_syndrome_10,300804/Retinitis_pigmentosa_23,300424],300515_[FANCB_Fanconi_anemia,complementation_group_B,300514],311770_[PIGA_Paroxysmal_nocturnal_hemoglobinuria,somatic,300818/Multiple_congenital_anomalies-hypotonia-seizures_syndrome_2,300868],300629_[AP1S2_Mental_retardation,X-linked_syndromic_5,304340],300457_[NHS_Nance-Horan_syndrome,302350/Cataract_40,X-linked,302200],300203_[CDKL5_Epileptic_encephalopathy,early_infantile,2,300672],300839_[RS1_Retinoschisis,312700],300798_[PHKA2_Glycogen_storage_disease,type_IXa1,306000/Glycogen_storage_disease,type_IXa2,306000],300572_[ADGRG2_Congenital_bilateral_absence_of_vas_deferens,X-linked,300985],300502_[PDHA1_Pyruvate_dehydrogenase_E1-alpha_deficiency,312170],300075_[RPS6KA3_Coffin-Lowry_syndrome,303600/Mental_retardation,X-linked_19,300844]
chrX	20211595	31341785	2	344	108	11130.190	0.006	RPS6KA3,CNKSR2,MBTPS2,SMS,PTCHD1,KLHL15,EIF2S3,ARX,IL1RAPL1,NR0B1,GK,GK-AS1,DMD	0.00000	yes	yes	RPS6KA3,SMS,PHEX,DDX53,PTCHD1,ARX,IL1RAPL1,NR0B1,GK,DMD	300075_[RPS6KA3_Coffin-Lowry_syndrome,303600/Mental_retardation,X-linked_19,300844],300724_[CNKSR2_Mental_retardation,X-linked,syndromic,Houge_type,301008],300226_[SMPX_Deafness,X-linked_4,300066],300294_[MBTPS2_IFAP_syndrome_with_or_without_BRESHECK_syndrome,308205/Keratosis_follicularis_spinulosa_decalvans,X-linked,308800/Olmsted_syndrome,X-linked,300918/Osteogenesis_imperfecta,type_XIX,301014],300105_[SMS_Mental_retardation,X-linked,Snyder-Robinson_type,309583],300550_[PHEX_Hypophosphatemic_rickets,X-linked_dominant,307800],300828_[PTCHD1_Autism,susceptibility_to,X-linked_4,300830],300980_[KLHL15_Mental_retardation,X-linked_103,300982],300161_[EIF2S3_MEHMO_syndrome,300148],300906_[PDK3_Charcot-Marie-Tooth_disease,X-linked_dominant,6,300905],312040_[POLA1_Pigmentary_disorder,reticulate,with_systemic_manifestations,X-linked,301220],300203_[ARX_Epileptic_encephalopathy,early_infantile,2,300672],300382_[ARX_Epileptic_encephalopathy,early_infantile,1,308350/Lissencephaly,X-linked_2,300215/Mental_retardation,X-linked_29_and_others,300419/Proud_syndrome,300004/Partington_syndrome,309510/Hydranencephaly_with_abnormal_genitalia,300215],300206_[IL1RAPL1_Mental_retardation,X-linked_21/34,300143],300473_[NR0B1_Adrenal_hypoplasia,congenital,300200/46XY_sex_reversal_2,dosage-sensitive,300018],300474_[GK_Glycerol_kinase_deficiency,307030],300377_[DMD_Duchenne_muscular_dystrophy,310200/Becker_muscular_dystrophy,300376/Cardiomyopathy,dilated,3B,302045]
chrX	31514895	31525580	2	6	2	   10.685	0.006	DMD	0.01027			DMD	300377_[DMD_Duchenne_muscular_dystrophy,310200/Becker_muscular_dystrophy,300376/Cardiomyopathy,dilated,3B,302045]
chrX	31676097	44879985	2	554	152	13203.888	0.006	DMD,CYBB,TSPAN7,OTC,BCOR,ATP6AP2,CASK,CASK-AS1,MAOA,NDP,NDP-AS1,KDM6A	0.00000	yes	yes	DMD,TSPAN7,CYBB,OTC,BCOR,ATP6AP2,NYX,CASK,MAOA,NDP,EFHC2,KDM6A	300377_[DMD_Duchenne_muscular_dystrophy,310200/Becker_muscular_dystrophy,300376/Cardiomyopathy,dilated,3B,302045],300096_[TSPAN7_Mental_retardation,X-linked_58,300210],314850_[XK_McLeod_syndrome_with_or_without_chronic_granulomatous_disease,300842],300481_[CYBB_Chronic_granulomatous_disease,X-linked,306400/Immunodeficiency_34,mycobacteriosis,X-linked,300645],312610_[RPGR_Retinitis_pigmentosa_3,300029/Retinitis_pigmentosa,X-linked,and_sinorespiratory_infections,with_or_without_deafness,300455/Macular_degeneration,X-linked_atrophic,300834/Cone-rod_dystrophy,X-linked,1,304020],300461_[OTC_Ornithine_transcarbamylase_deficiency,311250],300485_[BCOR_Microphthalmia,syndromic_2,300166],300556_[ATP6AP2_Mental_retardation,X-linked,syndromic,Hedera_type,300423/Parkinsonism_with_spasticity,X-linked,300911],300072_[USP9X_Mental_retardation,X-linked_99,300919/Mental_retardation,X-linked_99,syndromic,female-restricted,300968],300160_[DDX3X_Mental_retardation,X-linked_102,300958],300278_[NYX_Night_blindness,congenital_stationary_(complete),1A,X-linked,310500],300172_[CASK_Mental_retardation_and_microcephaly_with_pontine_and_cerebellar_hypoplasia,300749/FG_syndrome_4,300422/Mental_retardation,with_or_without_nystagmus,300422],309850_[MAOA_Brunner_syndrome,300615/Antisocial_behavior,300615],300658_[NDP_Norrie_disease,310600/Exudative_vitreoretinopathy_2,X-linked,305390],300128_[KDM6A_Kabuki_syndrome_2,300867]
chrX	44922657	54496900	2	919	390	 9574.243	0.006	KDM6A,NDUFB11,RBM10,UBA1,CDK16,ARAF,SYN1,CFP,FTSJ1,PORCN,WAS,PQBP1,TIMM17B,SYP,SYP-AS1,CACNA1F,CCDC22,FOXP3,USP27X,CLCN5,SHROOM4,KDM5C,IQSEC2,SMC1A,HSD17B10,HUWE1,PHF8,FGD1,TSR2	0.00000	yes	yes	KDM6A,ZNF674,RP2,ZNF41,SYN1,ELK1,ZNF81,SLC38A5,FTSJ1,PORCN,EBP,PQBP1,CLCN5,SHROOM4,KDM5C,SMC1A,HSD17B10,HUWE1,PHF8,FGD1	300128_[KDM6A_Kabuki_syndrome_2,300867],300851_[ZNF674_Mental_retardation,X-linked_92],300757_[RP2_Retinitis_pigmentosa_2,312600],300403_[NDUFB11_Linear_skin_defects_with_multiple_congenital_anomalies_3,300952/Mitochondrial_complex_I_deficiency,nuclear_type_30,301021],300080_[RBM10_TARP_syndrome,311900],314370_[UBA1_Spinal_muscular_atrophy,X-linked_2,infantile,301830],300848_[ZNF41_Mental_retardation,X-linked_89],313440_[SYN1_Epilepsy,X-linked,with_variable_learning_disabilities_and_behavior_disorders,300491],300383_[CFP_Properdin_deficiency,X-linked,312060],300498_[ZNF81_Mental_retardation,X-linked_45],312820_[SSX1_Sarcoma,synovial,300813],300499_[FTSJ1_Mental_retardation,X-linked_9/44,309549],300651_[PORCN_Focal_dermal_hypoplasia,305600],300205_[EBP_Chondrodysplasia_punctata,X-linked_dominant,302960/MEND_syndrome,300960],300392_[WAS_Wiskott-Aldrich_syndrome,301000/Thrombocytopenia,X-linked,313900/Neutropenia,severe_congenital,X-linked,300299/Thrombocytopenia,X-linked,intermittent,313900],305371_[GATA1_Thrombocytopenia,X-linked,with_or_without_dyserythropoietic_anemia,300367/Leukemia,megakaryoblastic,with_or_without_Down_syndrome,somatic,190685/Thrombocytopenia_with_beta-thalassemia,X-linked,314050/Anemia,X-linked,with/without_neutropenia_and/or_platelet_abnormalities,300835],300272_[HDAC6_Chondrodysplasia_with_platyspondyly,distinctive_brachydactyly,hydrocephaly,and_microphthalmia,300863],300428_[PQBP1_Mental_retardation,X-linked_2],300032_[PQBP1_Alpha-thalassemia/mental_retardation_syndrome,301040/Alpha-thalassemia_myelodysplasia_syndrome,somatic,300448/Mental_retardation-hypotonic_facies_syndrome,X-linked,309580],300806_[PQBP1_Mental_retardation,X-linked,FRAXE_type,309548],300463_[PQBP1_Renpenning_syndrome,309500],314375_[SLC35A2_Congenital_disorder_of_glycosylation,type_IIm,300896],314310_[TFE3_Renal_cell_carcinoma,papillary,1,300854],300526_[WDR45_Neurodegeneration_with_brain_iron_accumulation_5,300894],313475_[SYP_Mental_retardation,X-linked_96,300802],300110_[CACNA1F_Night_blindness,congenital_stationary_(incomplete),2A,X-linked,300071/Cone-rod_dystrophy,X-linked,3,300476/Aland_Island_eye_disease,300600],300859_[CCDC22_Ritscher-Schinzel_syndrome_2,300963],300292_[FOXP3_Immunodysregulation,polyendocrinopathy,and_enteropathy,X-linked,304790/Diabetes_mellitus,type_I,susceptibility_to,222100],300975_[USP27X_Mental_retardation,X-linked_105,300984],300008_[CLCN5_Dent_disease,300009/Nephrolithiasis,type_I,310468/Hypophosphatemic_rickets,300554/Proteinuria,low_molecular_weight,with_hypercalciuric_nephrocalcinosis,308990],300535_[CLCN5_Lowe_syndrome,309000/Dent_disease_2,300555],300579_[SHROOM4_Stocco_dos_Santos_X-linked_mental_retardation_syndrome,300434],300247_[BMP15_Ovarian_dysgenesis_2,300510/Premature_ovarian_failure_4,300510],300192_[SSX2_Sarcoma,synovial,300813],314690_[KDM5C_Mental_retardation,X-linked,syndromic,Claes-Jensen_type,300534],300522_[IQSEC2_Mental_retardation,X-linked_1/78,309530],300040_[SMC1A_Cornelia_de_Lange_syndrome_2,300590],300256_[HSD17B10_HSD10_mitochondrial_disease,300438],300697_[HUWE1_Mental_retardation,X-linked_syndromic,Turner_type,300706],300560_[PHF8_Mental_retardation_syndrome,X-linked,Siderius_type,300263],300945_[TSR2_Diamond-Blackfan_anemia_14_with_mandibulofacial_dysostosis,300946],300546_[FGD1_Aarskog-Scott_syndrome,305400/Mental_retardation,X-linked_syndromic_16,305400]
chrX	56276654	56292187	2	10	2	   15.533	0.006	KLF8	0.00047			KLF8	
chrX	56310736	56314332	2	10	1	    3.596	0.006	KLF8	0.00000			KLF8	
chrX	64135672	70465345	2	421	176	 6329.673	0.006	ZC4H2,LAS1L,AR,OPHN1,EFNB1,EDA,IGBP1,IGBP1-AS2,KIF4A,DLG3,DLG3-AS1,IL2RG,MED12,NLGN3,GJB1,ZMYM3	0.00000	yes	yes	AR,OPHN1,EFNB1,EDA,DLG3,NLGN3,ZMYM3	300897_[ZC4H2_Wieacker-Wolff_syndrome,314580],300964_[LAS1L_Wilson-Turner_syndrome,309585],309845_[MSN_Immunodeficiency_50,300988],313700_[AR_Androgen_insensitivity,300068/Spinal_and_bulbar_muscular_atrophy_of_Kennedy,313200/Androgen_insensitivity,partial,with_or_without_breast_cancer,312300/Prostate_cancer,susceptibility_to,176807/Hypospadias_1,X-linked,300633],300127_[OPHN1_Mental_retardation,X-linked,with_cerebellar_hypoplasia_and_distinctive_facial_appearance,300486],300035_[EFNB1_Craniofrontonasal_dysplasia,304110],300451_[EDA_Ectodermal_dysplasia_1,hypohidrotic,X-linked,305100/Tooth_agenesis,selective,X-linked_1,313500],300139_[IGBP1_Corpus_callosum,agenesis_of,with_mental_retardation,ocular_coloboma_and_micrognathia,300472],301770_[ARR3_Myopia_26,X-linked,female-limited,301010],300521_[KIF4A_Mental_retardation,X-linked_100,300923],300189_[DLG3_Mental_retardation,X-linked_90,300850],300311_[TEX11_Spermatogenic_failure,X-linked,2,309120],308380_[IL2RG_Severe_combined_immunodeficiency,X-linked,300400/Combined_immunodeficiency,X-linked,moderate,312863],300188_[MED12_Opitz-Kaveggia_syndrome,305450/Lujan-Fryns_syndrome,309520/Ohdo_syndrome,X-linked,300895],300336_[NLGN3_Autism_susceptibility,X-linked_1,300425/Asperger_syndrome_susceptibility,X-linked_1,300494],304040_[GJB1_Charcot-Marie-Tooth_neuropathy,X-linked_dominant,1,302800]
chrX	70468002	70468172	2	3	1	    0.170	0.006	ZMYM3	0.05331			ZMYM3	
chrX	70468859	106894266	2	805	269	36425.407	0.006	ZMYM3,TAF1,SLC16A2,PABPC1P3,RLIM,NEXMIF,ZDHHC15,ATRX,MAGT1,ATP7A,PGK1,BRWD3,ZNF711,PCDH19,SRPX2,CSTF2,TAF7L,TIMM8A,BTK,GLA,RPL36A-HNRNPH2,RAB40AL,PLP1,PRPS1	0.00000	yes	yes	ZMYM3,XIST,SLC16A2,NEXMIF,ZDHHC15,ATRX,MAGT1,ATP7A,PGK1,BRWD3,POU3F4,ZNF711,CHM,PCDH19,SRPX2,TIMM8A,BTK,GLA,NXF5,PLP1,PRPS1	300084_[NONO_Mental_retardation,X-linked,syndromic_34,300967],313650_[TAF1_Dystonia-Parkinsonism,X-linked,314250/Mental_retardation,X-linked,syndromic_33,300966],300255_[OGT_Mental_retardation,X-linked_106,300997],300964_[HDAC8_Wilson-Turner_syndrome,309585],300269_[HDAC8_Cornelia_de_Lange_syndrome_5,300882],311870_[PHKA1_Muscle_glycogenosis,300559],314670_[XIST_X-inactivation,familial_skewed,300087],300095_[SLC16A2_Allan-Herndon-Dudley_syndrome,300523],300379_[RLIM_Tonne-Kalscheuer_syndrome,300978],300524_[NEXMIF_Mental_retardation,X-linked_98,300912],300135_[ABCB7_Anemia,sideroblastic,with_ataxia,301310],300576_[ZDHHC15_Mental_retardation,X-linked_91,300577],300827_[FGF16_Metacarpal_4-5_fusion,309630],300504_[ATRX_Mental_retardation,X-linked_52],300032_[ATRX_Alpha-thalassemia/mental_retardation_syndrome,301040/Alpha-thalassemia_myelodysplasia_syndrome,somatic,300448/Mental_retardation-hypotonic_facies_syndrome,X-linked,309580],300715_[MAGT1_Immunodeficiency,X-linked,with_magnesium_defect,Epstein-Barr_virus_infection_and_neoplasia,300853],300716_[MAGT1_Mental_retardation,X-linked_95],300885_[COX7B_Linear_skin_defects_with_multiple_congenital_anomalies_2,300887],300011_[ATP7A_Menkes_disease,309400/Occipital_horn_syndrome,304150/Spinal_muscular_atrophy,distal,X-linked_3,300489],311800_[PGK1_Phosphoglycerate_kinase_1_deficiency,300653],300205_[TBX22_Chondrodysplasia_punctata,X-linked_dominant,302960/MEND_syndrome,300960],300307_[TBX22_Cleft_palate_with_ankyloglossia,303400/Abruzzo-Erickson_syndrome,302905],300553_[BRWD3_Mental_retardation,X-linked_93,300659],300039_[POU3F4_Deafness,X-linked_2,304400],314990_[ZNF711_Mental_retardation,X-linked_97,300803],300603_[POF1B_Premature_ovarian_failure_2B,300604],300390_[CHM_Choroideremia,303100],300108_[DIAPH2_Premature_ovarian_failure_2A,300511],300460_[PCDH19_Epileptic_encephalopathy,early_infantile,9,300088],300642_[SRPX2_Rolandic_epilepsy,mental_retardation,and_speech_dyspraxia,300643],300356_[TIMM8A_Mohr-Tranebjaerg_syndrome,304700],300300_[BTK_Agammaglobulinemia,X-linked_1,300755/Isolated_growth_hormone_deficiency,type_III,with_agammaglobulinemia,307200],300644_[GLA_Fabry_disease,301500/Fabry_disease,cardiac_variant,301500],300610_[HNRNPH2_Mental_retardation,X-linked,syndromic,Bain_type,300986],300969_[GPRASP2_Deafness,X-linked_7,301018],300401_[PLP1_Pelizaeus-Merzbacher_disease,312080/Spastic_paraplegia_2,X-linked,312920],314200_[SERPINA7_Thyroxine-binding_globulin_QTL,300932],300933_[PIH1D3_Ciliary_dyskinesia,primary,36,X-linked,300991],311850_[PRPS1_Gout,PRPS-related,300661/Phosphoribosylpyrophosphate_synthetase_superactivity,300661/Charcot-Marie-Tooth_disease,X-linked_recessive,5,311070/Arts_syndrome,301835/Deafness,X-linked_1,304500]
chrX	107829835	107829987	2	7	1	    0.152	0.006	COL4A5	0.00959			COL4A5	303630_[COL4A5_Alport_syndrome,301050]
chrX	107867456	107867574	2	7	1	    0.118	0.006	COL4A5	0.00232			COL4A5	303630_[COL4A5_Alport_syndrome,301050]
chrX	107938027	122745377	2	333	109	14807.350	0.006	COL4A5,ACSL4,PAK3,DCX,ZCCHC12,UBE2A,UPF3B,NDUFA1,RNF113A,LAMP2,CUL4B,GRIA3,THOC2	0.00000	yes	yes	COL4A5,ACSL4,CHRDL1,PAK3,DCX,AGTR2,UBE2A,UPF3B,LAMP2,CUL4B,GRIA3	303630_[COL4A5_Alport_syndrome,301050],300157_[ACSL4_Mental_retardation,X-linked_63,300387],300195_[AMMECR1_Midface_hypoplasia,hearing_impairment,elliptocytosis,and_nephrocalcinosis,300990],300350_[CHRDL1_Megalocornea_1,X-linked_309300],300142_[PAK3_Mental_retardation,X-linked_30/47,300558],300121_[DCX_Lissencephaly,X-linked,300067/Subcortical_laminal_heterotopia,X-linked,300067],300776_[ALG13_Epileptic_encephalopathy,early_infantile,36,300884/Congenital_disorder_of_glycosylation,type_Is,300884],300131_[PLS3_Bone_mineral_density_QTL18,osteoporosis,300910],300852_[AGTR2_Mental_retardation,X-linked_88],300444_[SLC6A14_Obesity,susceptibility_to,BMIQ11,300306],301012_[CXORF56_Mental_retardation,X-linked_107,301013],312180_[UBE2A_Mental_retardation,X-linked_syndromic,Nascimento-type,300860],300298_[UPF3B_Mental_retardation,X-linked,syndromic_14,300676],300951_[RNF113A_Trichothiodystrophy_5,nonphotosensitive,300953],300078_[NDUFA1_Mitochondrial_complex_I_deficiency,nuclear_type_12,301020],309060_[LAMP2_Danon_disease,300257],300304_[CUL4B_Mental_retardation,X-linked,syndromic_15_(Cabezas_type),300354],300611_[C1GALT1C1_Tn_polyagglutination_syndrome,somatic,300622],300144_[GLUD2_Parkinson_disease,age_of_onset,modifier,168600],305915_[GRIA3_Mental_retardation,X-linked_94,300699],300395_[THOC2_Mental_retardation,X-linked_12/35,300957]
chrX	122747893	122748050	2	4	1	    0.157	0.006	THOC2	0.01735				300395_[THOC2_Mental_retardation,X-linked_12/35,300957]
chrX	122757901	122758052	2	8	1	    0.151	0.006	THOC2	0.00235				300395_[THOC2_Mental_retardation,X-linked_12/35,300957]
chrX	122765529	122765713	2	4	1	    0.184	0.006	THOC2	0.00613				300395_[THOC2_Mental_retardation,X-linked_12/35,300957]
chrX	122767794	122767931	2	5	1	    0.137	0.006	THOC2	0.00886				300395_[THOC2_Mental_retardation,X-linked_12/35,300957]
chrX	122771884	128691937	2	88	25	 5920.053	0.006	THOC2,XIAP,SH2D1A,OCRL	0.00000	yes	yes	XIAP,SH2D1A,OCRL	300395_[THOC2_Mental_retardation,X-linked_12/35,300957],300079_[XIAP_Lymphoproliferative_syndrome,X-linked,2,300635],300490_[SH2D1A_Lymphoproliferative_syndrome,X-linked,1,308240],300535_[OCRL_Lowe_syndrome,309000/Dent_disease_2,300555]
chrX	128694517	154493862	2	1223	391	25799.345	0.006	OCRL,ZDHHC9,AIFM1,GPC3,PHF6,HPRT1,SLC9A6,FHL1,CD40LG,ARHGEF6,ZIC3,F9,SOX3,FMR1,AFF2,IDS,MTM1,NSDHL,SLC6A8,ABCD1,L1CAM,AVPR2,HCFC1,MECP2,FLNA,EMD,RPL10,DNASE1L1,TAZ,GDI1,G6PD,IKBKG,DKC1,F8,RAB39B	0.00000	yes	yes	OCRL,ZDHHC9,FRMD7,GPC3,PHF6,HPRT1,SLC9A6,ARHGEF6,ZIC3,F9,SOX3,FMR1,AFF2,IDS,MTM1,NSDHL,FAM58A,SLC6A8,ABCD1,L1CAM,CEP290,AVPR2,MECP2,OPN1LW,OPN1MW,TEX28,FLNA,EMD,GDI1,IKBKG,DKC1,F8,VBP1,RAB39B	300535_[OCRL_Lowe_syndrome,309000/Dent_disease_2,300555],300145_[XPNPEP2_Angioedema_induced_by_ACE_inhibitors,susceptibility_to,300909],300646_[ZDHHC9_Mental_retardation,X-linked_syndromic,Raymond_type,300799],300169_[AIFM1_Combined_oxidative_phosphorylation_deficiency_6,300816/Cowchock_syndrome,310490/Deafness,X-linked_5,300614],300137_[IGSF1_Hypothyroidism,central,and_testicular_enlargement,300888],300628_[FRMD7_Nystagmus_1,congenital,X-linked,310700/Nystagmus,infantile_periodic_alternating,X-linked,310700],300037_[GPC3_Simpson-Golabi-Behmel_syndrome,type_1,312870/Wilms_tumor,somatic,194070],300414_[PHF6_Borjeson-Forssman-Lehmann_syndrome,301900],308000_[HPRT1_Lesch-Nyhan_syndrome,300322/HPRT-related_gout,300323],300231_[SLC9A6_Mental_retardation,X-linked_syndromic,Christianson_type,300243],300163_[FHL1_Scapuloperoneal_myopathy,X-linked_dominant,300695/Myopathy,X-linked,with_postural_muscle_atrophy,300696/Reducing_body_myopathy,X-linked_1a,severe,infantile_or_early_childhood_onset,300717/Reducing_body_myopathy,X-linked_1b,with_late_childhood_or_adult_onset,300718/Emery-Dreifuss_muscular_dystrophy_6,X-linked,300696/Uruguay_faciocardiomusculoskeletal_syndrome,300280],300386_[CD40LG_Immunodeficiency,X-linked,with_hyper-IgM,308230],300436_[ARHGEF6_Mental_retardation,X-linked_46],300199_[RBMX_Mental_retardation,X-linked,syndromic_11,Shashi_type,300238],300393_[GPR101_Pituitary_adenoma_2,GH-secreting,300943],300265_[ZIC3_Heterotaxy,visceral,1,X-linked_306955/Congenital_heart_defects,nonsyndromic,1,X-linked,306955/VACTERL_association,X-linked,314390],300746_[F9_Hemophilia_B,306900/Warfarin_sensitivity,122700/Thrombophilia,X-linked,due_to_factor_IX_defect,300807/Deep_venous_thrombosis,protection_against,300807],300516_[ATP11C_Hemolytic_anemia,congenital,X-linked,301015],313430_[SOX3_Mental_retardation,X-linked,with_isolated_growth_hormone_deficiency,300123/Panhypopituitarism,X-linked,312000],309550_[FMR1_Fragile_X_syndrome,300624/Fragile_X_tremor/ataxia_syndrome,300623/Premature_ovarian_failure_1,311360],300806_[AFF2_Mental_retardation,X-linked,FRAXE_type,309548],300823_[IDS_Mucopolysaccharidosis_II,309900],300120_[MAMLD1_Hypospadias_2,X-linked,300758],300415_[MTM1_Myotubular_myopathy,X-linked,310400],300193_[HMGB3_Microphthalmia,syndromic_13,300915],300913_[VMA21_Myopathy,X-linked,with_excessive_autophagy,310440],300275_[NSDHL_CHILD_syndrome,308050/CK_syndrome,300831],301870_[BGN_Spondyloepimetaphyseal_dysplasia,X-linked,300106/Meester-Loeys_syndrome,300989],300014_[ATP2B3_Spinocerebellar_ataxia,X-linked_1,302500],300708_[CCNQ_STAR_syndrome,300707],300036_[SLC6A8_Cerebral_creatine_deficiency_syndrome_1,300352],300398_[BCAP31_Deafness,dystonia,and_cerebral_hypomyelination,300475],300371_[ABCD1_Adrenoleukodystrophy,300100/Adrenomyeloneuropathy,adult,300100],300090_[SSR4_Congenital_disorder_of_glycosylation,type_Iy,300934],308840_[L1CAM_Hydrocephalus_due_to_aqueductal_stenosis,307000/MASA_syndrome,303350/CRASH_syndrome,303350/Hydrocephalus_with_Hirschsprung_disease,307000/Hydrocephalus_with_congenital_idiopathic_intestinal_pseudoobstruction,307000/Corpus_callosum,partial_agenesis_of,304100],300538_[AVPR2_Diabetes_insipidus,nephrogenic,304800/Nephrogenic_syndrome_of_inappropriate_antidiuresis,300539],300013_[NAA10_Ogden_syndrome,300855/Microphthalmia,syndromic_1,309800],300019_[HCFC1_Mental_retardation,X-linked_3_(methylmalonic_acidemia_and_homocysteinemia,cblX_type_),309541],300005_[MECP2_Rett_syndrome,312750/Mental_retardation,X-linked,syndromic_13,300055/Rett_syndrome,preserved_speech_variant,312750/Encephalopathy,neonatal_severe,300673/Autism_susceptibility,X-linked_3,300496/Mental_retardation,X-linked_syndromic,Lubs_type,300260/Rett_syndrome,atypical,312750],300822_[OPN1LW_Colorblindness,protan,303900/Blue_cone_monochromacy,303700],300821_[OPN1MW_Colorblindness,deutan,303800/Blue_cone_monochromacy,303700],300017_[FLNA_Heterotopia,periventricular,1,300049/Otopalatodigital_syndrome,type_I,311300/Otopalatodigital_syndrome,type_II,304120/Intestinal_pseudoobstruction,neuronal,300048/Melnick-Needles_syndrome,309350/Frontometaphyseal_dysplasia_1,305620/FG_syndrome_2,300321/Cardiac_valvular_dysplasia,X-linked,314400/Terminal_osseous_dysplasia,300244/Congenital_short_bowel_syndrome,300048],300384_[EMD_Emery-Dreifuss_muscular_dystrophy_1,X-linked,310300],312173_[RPL10_Autism,susceptibility_to,X-linked_5,300847/Mental_retardation,X-linked,syndromic,35,300998],300394_[TAZ_Barth_syndrome,302060],300197_[ATP6AP1_Immunodeficiency_47,300972],300104_[GDI1_Mental_retardation,X-linked_41,300849],300060_[LAGE3_Galloway-Mowat_syndrome_2,X-linked,301006],305900_[G6PD_Hemolytic_anemia,G6PD_deficient_(favism),300908/Resistance_to_malaria_due_to_G6PD_deficiency,611162],300248_[IKBKG_Incontinentia_pigmenti,308300/Ectodermal_dysplasia_and_immunodeficiency_1,300291/Ectodermal,dysplasia,anhidrotic,lymphedema_and_immunodeficiency,300301/Immunodeficiency,isolated,300584/Immunodeficiency_33,300636/Invasive_pneumococcal_disease,recurrent_isolated,2,300640],300126_[DKC1_Dyskeratosis_congenita,X-linked,305000],300841_[F8_Hemophilia_A,306700],300774_[RAB39B_Mental_retardation,X-linked_72,300271/Waisman_syndrome,311510]
